{"numRecords":"611","DataElementQueryResults":[{"publicId":"2963688","version":"1","preferredName":"Soft Tissue Sarcoma Histologic Grade Type","preferredDefinition":"Text term that represents the risk group associated with soft tissue sarcoma.","longName":"2963683v1.0:2963685v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7966FC1B-51FD-A951-E040-BB89AD43248A","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"COOPERM","dateModified":"2017-10-17","changeNote":"11/23/11mn-updated after changes to VD. added cs for disease status & added contact info. 12/16/11: updated to reflect the change of VD.wz Retired due to not in use and as part of the caDSR cleanup. AK 6/30/17. 09/22/2017 wz changed status to Released to be used by HCMI task. 10/17/17 Changed context to OCG and source to HCMI with permission of NMDP, AK. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2978013","version":"1","preferredName":"Surgical Procedure First Treatment Plan Performed Indicator","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Preceding all others in time or space or degree._A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs._Executed and carried through to completion._Indicator of Yes, No, Unknown, Not Done, or Not Applicable to a question.[manually curated]","longName":"2977994v1.0:2784450v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C6DF516-248E-758D-E040-BB89AD4317E5","latestVersionIndicator":"Yes","beginDate":"2010-01-05","endDate":null,"createdBy":"WHITES","dateCreated":"2010-01-05","modifiedBy":"GDEEN","dateModified":"2023-07-17","changeNote":"2020-10-19 ak Moved RETIRED WITHDRAWN content to RETIRED ARCHIVED for MDR.; Retired due to not in use and as part of the csDAR cleanup. AK 8/15/18","administrativeNotes":"07.17.23_Transferred ownership of DEC/VD/CDE to OCG/HCMI for use in Melanoma template.  Reset WFS and RS_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214615","version":"1","preferredName":"Biospecimen Primary Histology Name","preferredDefinition":"Text term that represents named classification for the primary biospecimen histology.","longName":"4191240v1.0:4214603v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46DA4A4-15BB-3FBD-E040-BB89AD431BE9","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Moved CDEs to new CTD-2 Context folder. mc 12/21/15 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214626","version":"2","preferredName":"Biospecimen Primary Histology Subtype 1 Name","preferredDefinition":"Named histologic classification that is a subtype of the primary biospecimen histology.","longName":"PRM_HISTO_SUB1_NM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8CB9F6A5-070B-65B5-E053-F662850A2B21","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-02","modifiedBy":"COOPERM","dateModified":"2019-07-02","changeNote":"VM concept annotation complete and CDEs released. mc 10/7/16 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17 Versioned for non-numeric short name per NRG request for Rave. mc 7.2.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214629","version":"1","preferredName":"Biospecimen Primary Anatomic Site Name","preferredDefinition":"Text term that represents named locations of, or within, the body that are the primary source for a biospecimen.","longName":"3253891v1.0:4214607v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46DE966-0DCB-E56A-E040-BB89AD4311DA","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"COOPERM","dateModified":"2021-03-03","changeNote":"Moved CDEs to new CTD-2 Context folder. mc 12/21/15 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4214651","version":"1","preferredName":"Biospecimen Primary Anatomic Site Subtype 1 Name","preferredDefinition":"Named locations of, or within, the body that are a subtype of the primary biospecimen source.","longName":"4214594v1.0:4214614v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46DE966-0E10-E56A-E040-BB89AD4311DA","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"VM concept annotation complete and CDEs released. mc 10/7/16 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4215492","version":"1","preferredName":"Biospecimen Primary Histology Subtype 2 Name","preferredDefinition":"Named histologic classification that is a secondary subtype of the primary biospecimen histology.","longName":"4191243v1.0:4214692v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46DE966-0EAC-E56A-E040-BB89AD4311DA","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"VM concept annotation complete and CDEs released. mc 10/7/16 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4215496","version":"1","preferredName":"Biospecimen Primary Anatomic Site Subtype 2 Name","preferredDefinition":"Named locations of, or within, the body that are a secondary subtype of the primary biospecimen source.","longName":"4214594v1.0:4215489v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46DE966-0EEE-E56A-E040-BB89AD4311DA","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"VM concept annotation complete and CDEs released. mc 10/7/16 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4633600","version":"2","preferredName":"Acute Lymphoblastic Leukemia Cell Origin Type","preferredDefinition":"Text term that represents the kind of cell related to the origin of acute lymphoblastic leukemia.","longName":"4633586v1.0:4633578v1.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDC8F7-4925-2FDC-E053-F662850A8BE4","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"KUMMEROA","dateModified":"2022-06-02","changeNote":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/15/2014 Versioned to extend max length. mc 12.14.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042426","version":"1","preferredName":"Cell Line Name","preferredDefinition":"Text term that represents the name of the cell line.","longName":"5038912v1.0:5040111v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AE3F-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042456","version":"1","preferredName":"Tissue Sample Name","preferredDefinition":"Text term that represents the name of the tissue sample.","longName":"2611860v1.0:5040115v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AEA4-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk removed MCL CSI, Used by.  Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042457","version":"1","preferredName":"Compound Source Identifier","preferredDefinition":"Text term that represents the local identifier for the source compound.","longName":"5038914v1.0:5040116v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-75D4-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042459","version":"1","preferredName":"Compound Name","preferredDefinition":"Text term that represents the name of the compound.","longName":"2535162v1.0:5040117v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A7E9C9-AEEA-C143-E050-BB89AD43576C","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042460","version":"1","preferredName":"Compound SMILES Text","preferredDefinition":"Text term that represents the line notation for entering and representing molecules of the compound chemical structure without the use of a special data type or drawing.","longName":"5038921v1.0:5040118v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-75FB-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042461","version":"1","preferredName":"Compound Concentration Value","preferredDefinition":"The number that represents the concentration of the compound measured in micromoles.","longName":"5038923v1.0:5040131v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7622-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042462","version":"1","preferredName":"Entrez Gene Identifier","preferredDefinition":"Numeric and alphabetic characters that represent the accession identifier for a protein or gene within the Entrez Gene database.","longName":"5038926v1.0:5040133v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7649-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042463","version":"1","preferredName":"HUGO Gene Symbol Name","preferredDefinition":"Text term that represents the unique gene name approved by an organism specific nomenclature committee.","longName":"5038929v1.0:2956133v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7670-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042464","version":"1","preferredName":"Feature Dataset Name","preferredDefinition":"Text term that represents the name of the related data records  from which lineage cells are made.","longName":"5038934v1.0:5040134v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7697-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042465","version":"1","preferredName":"Differential Methylation P Value","preferredDefinition":"The number that represents a p-value reflecting the difference between at least two methylation states.","longName":"5038937v1.0:5040138v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-76BE-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042466","version":"1","preferredName":"Gene Enrichment Probability P Value","preferredDefinition":"The number that represents the probability of cell lines positive for a feature enriched by chance.","longName":"5038940v1.0:5040138v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-76E5-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042467","version":"1","preferredName":"False Discovery Rate Value","preferredDefinition":"The number that represents the expected proportion of false positives (Type I error) among rejected tests or hypotheses.","longName":"5038943v1.0:5040138v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-770C-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042468","version":"1","preferredName":"False Discovery Rate Q Value","preferredDefinition":"The number that represents the minimum False Discovery Rate (FDR) value required for a test to be considered significant.","longName":"5038945v1.0:5040181v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7733-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042469","version":"1","preferredName":"Probability Measure P Value","preferredDefinition":"The number that represents the measure of the probability that a result happened by chance. The lower the p-value, the more likely it is that the result was caused by phenomenon of interest.","longName":"5038948v1.0:5040138v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A910CE-7767-6593-E050-BB89AD431F10","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042470","version":"1","preferredName":"Absolute Genomic Position Start Text","preferredDefinition":"Numeric and alphabetic characters that represent the coordinates to the start of a chromosome.","longName":"5038951v1.0:5040182v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9A794-B7BD-B9B4-E050-BB89AD4353F4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042471","version":"1","preferredName":"Absolute Genomic Position End Text","preferredDefinition":"Numeric and alphabetic characters that represent the coordinates to the end of a chromosome.","longName":"5038953v1.0:5040182v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9A794-B7FD-B9B4-E050-BB89AD4353F4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22\r\nMoved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042472","version":"1","preferredName":"Gene Amplification Frequency Value","preferredDefinition":"The number that represents the frequency of gene amplifications.","longName":"5038956v1.0:5040195v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9A794-B845-B9B4-E050-BB89AD4353F4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"NIKITAP","dateModified":"2022-02-24","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042473","version":"1","preferredName":"Gene Deletion Frequency Value","preferredDefinition":"The number that represents the frequency of gene deletions.","longName":"5038960v1.0:5040195v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9A794-B86C-B9B4-E050-BB89AD4353F4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042474","version":"1","preferredName":"Area Under Concentration Response Curve Value","preferredDefinition":"The number that represents the calculated area under the spline-fit concentration-response curve.","longName":"5038963v1.0:5040197v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FB5E-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042475","version":"1","preferredName":"Average Percent Viabilty Value","preferredDefinition":"The number that represents the weighted percent-viability with error propagation.","longName":"5038973v1.0:5040198v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9A794-B893-B9B4-E050-BB89AD4353F4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042476","version":"1","preferredName":"Compound Clinical Trial Phase Type","preferredDefinition":"Text term that represents the clinical trial phase associated with the compound testing.","longName":"5038975v1.0:5040199v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FB85-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042477","version":"1","preferredName":"Condensed Robust Z Score Value","preferredDefinition":"The number that represents the calculated variation of the z-score (sensitive to outliers), which substitutes the outlier-insensitive median and median absolute deviation (MAD) for mean and standard deviation in the z-score calculation.","longName":"5038980v1.0:5040200v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FBBA-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042478","version":"1","preferredName":"GeneData Screener Condensed Activity Value","preferredDefinition":"The number that represents the value obtained from condensing three replicate measures, a strategy provided by GeneData Screener software.","longName":"5038993v1.0:5040201v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FBE1-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042479","version":"1","preferredName":"GeneData Screener Corrected Average Value","preferredDefinition":"The number that represents the average corrected value of three replicate measurements.","longName":"5039015v1.0:5042347v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FC08-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042480","version":"1","preferredName":"GeneData Screener Corrected Standard Deviation Value","preferredDefinition":"The number that represents the corrected standard deviation of three replicate measurements.","longName":"5039018v1.0:5042348v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23A9D571-FC3D-939E-E050-BB89AD43758B","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042481","version":"1","preferredName":"Gene Product Functional Type","preferredDefinition":"Text term that represents the kind of functional gene product such as transcription factor or signaling molecule.","longName":"5039471v1.0:5042349v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA1C2F-E9EE-AA1E-E050-BB89AD434BA4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042482","version":"1","preferredName":"GCT File Path Indicator","preferredDefinition":"Indicator of whether a GCT file specifying the path of the gene expression dataset was submitted.","longName":"5039474v1.0:5042351v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA21A7-5957-4A1C-E050-BB89AD434BA6","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042486","version":"1","preferredName":"Cell Line Growth Mode Type","preferredDefinition":"Text term that represents the kind of growth behavior of the cancer cell line in culture.","longName":"5039477v1.0:5042352v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA1C2F-EA3F-AA1E-E050-BB89AD434BA4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042489","version":"1","preferredName":"Short Hairpin RNA Name","preferredDefinition":"Text term that describes the name of the short hairpin RNA (shRNA).","longName":"5039517v1.0:5042353v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA56BD-C1AA-3A34-E050-BB89AD436B88","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042490","version":"1","preferredName":"Percent Compound Purity Value","preferredDefinition":"The number that represents the percent purity of the compound.","longName":"5039533v1.0:5042354v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA56BD-C1D1-3A34-E050-BB89AD436B88","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042491","version":"1","preferredName":"Affymetyrix Probe Identifier","preferredDefinition":"Text that represents the Affymetrix probeset identifier.","longName":"5039537v1.0:5042355v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA60E4-FF92-05A4-E050-BB89AD431726","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042492","version":"1","preferredName":"Raw Chemiluminescence Value","preferredDefinition":"The number that represents the raw observed chemiluminescence value.","longName":"5039541v1.0:5042357v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA8148-152D-256E-E050-BB89AD4341E4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042493","version":"1","preferredName":"shRNA Sequence Identifier","preferredDefinition":"The numeric and alphabetic characters that represent the short hairpin RNA sequences.","longName":"5039790v1.0:5042356v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA8148-1554-256E-E050-BB89AD4341E4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5042494","version":"1","preferredName":"ATARiS Gene Solution Name","preferredDefinition":"Text that represents the ATARiS solution name, including the binary indicator of which shRNA is used.","longName":"5039794v1.0:5042358v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"CTD2:Cancer Target Discovery and Development","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23AA8148-157B-256E-E050-BB89AD4341E4","latestVersionIndicator":"Yes","beginDate":"2015-11-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-03","modifiedBy":"COOPERM","dateModified":"2017-02-07","changeNote":"Curated to support CTD2 activity per request by S.Jagu. mc 11/3/15 Changed from caBIG to CTD-2 for COOPERM by script 15-DEC-22 Moved from CTD-2 to OCG Context per request by S.Jagu. mc 2/1/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832571","version":"1","preferredName":"Last Contact Date Less Biospecimen Collection Date Day Calculation Value","preferredDefinition":"Time interval from the date of the sample collection to the date of the last contact, represented as a calculated number of days.","longName":"5832570v1.0:3008213v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FCE8E6C-427D-16D8-E053-F662850A4E4E","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832923","version":"1","preferredName":"First Degree Relative Diagnosis Primary Malignant Neoplasm History Indicator","preferredDefinition":"Indicator of whether or not a first degree blood relative (living or dead) of an individual was diagnosed with a primary malignant neoplasm of the same or different type.","longName":"5832801v1.0:5832839v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD25745-172F-1B6E-E053-F662850A3BD5","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832924","version":"1","preferredName":"Prior Same Malignant Neoplasm Personal Medical History Indicator","preferredDefinition":"Indicator of whether or not an individual has a history of a prior malignancy of the same type.","longName":"5832806v1.0:2957977v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD26CB7-92B3-1FD6-E053-F662850A92ED","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832925","version":"1","preferredName":"Biospecimen Collection Timestamp Date and Time","preferredDefinition":"Date and time of the sample collection.","longName":"3192115v1.0:5832844v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD26CB7-92E4-1FD6-E053-F662850A92ED","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832926","version":"1","preferredName":"Biospecimen Insertion Medium Timestamp Date and Time","preferredDefinition":"Date and time of the sample being placed into a medium.","longName":"5832809v1.0:5832844v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD27674-FE45-2AC8-E053-F662850A7827","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832927","version":"1","preferredName":"Biospecimen Shipment Timestamp Date and Time","preferredDefinition":"Date and time of the sample shipment.","longName":"3192393v1.0:5832844v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD27A9C-5CC8-2E29-E053-F662850A3C30","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832928","version":"2","preferredName":"Neoadjuvant Chemotherapy Administered Type","preferredDefinition":"Text term that represents the kind of neoadjuvant chemotherapy given to an individual.","longName":"neoadjuvant_chemotherapy_admin","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6749EACB-22B0-3571-E053-F662850A16EC","latestVersionIndicator":"Yes","beginDate":"2018-03-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-13","modifiedBy":"COOPERM","dateModified":"2018-03-13","changeNote":"Versioned to change Long Name and add new version VD for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832929","version":"1","preferredName":"Data Collection Race Ethnic Group Allowed Indicator","preferredDefinition":"Indicator of whether or not data on an individual's Race or Ethnicity is allowed to be collected.","longName":"5832816v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FD27A9C-5D16-2E29-E053-F662850A3C30","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-18","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5845012","version":"1","preferredName":"Human Cancer Models Initiative Participant Identifier","preferredDefinition":"The unique identification for a participant using the HCM letter center code and number model code.","longName":"5845011v1.0:2016938v3.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"513D4DD0-3A3D-621C-E053-F662850A755B","latestVersionIndicator":"Yes","beginDate":"2017-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-05","modifiedBy":"COOPERM","dateModified":"2017-10-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5878828","version":"1","preferredName":"Patient History Other Malignant Neoplasm Not Currently Treated Indicator","preferredDefinition":"Indicator whether or not the patient has a history of any malignant disease other than the one for which they are currently being treated.","longName":"5878826v1.0:2957977v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"526CCF46-E2FD-6349-E053-F662850A04B6","latestVersionIndicator":"Yes","beginDate":"2017-06-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-20","modifiedBy":"COOPERM","dateModified":"2017-06-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5880217","version":"1","preferredName":"Esophageal Cancer Targeted Therapy Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to an individual with esophageal cancer.","longName":"5880216v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5280F09A-389B-5C74-E053-F662850A6691","latestVersionIndicator":"Yes","beginDate":"2017-06-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-06-21","modifiedBy":"COOPERM","dateModified":"2017-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5946219","version":"1","preferredName":"Biospecimen Tumor Other Anatomic Site","preferredDefinition":"Text description of another tumor anatomic site not previously listed or mentioned.","longName":"BIOSP_OTHR_SITE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57FEFFFE-F9DB-4F3E-E053-F662850A5B06","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-30","modifiedBy":"LISU","dateModified":"2022-05-23","changeNote":"Created to support eDC. 8/30/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5946730","version":"1","preferredName":"Disease or Disorder Prior Clinical History Diagnosis Method Type","preferredDefinition":"Text term that represents the kind of method used to determine the diagnosis of a disease based on prior clinical history.","longName":"5946729v1.0:2015230v3.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5813683D-921C-6ED1-E053-F662850A68A4","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-31","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for Pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983082","version":"2","preferredName":"Peripancreatic Lymph Node Positive Finding Range","preferredDefinition":"Numeric range of the number of paripancreatic lymph nodes with disease involvement.","longName":"PANCR_LYM_ND_POS_RNG","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6767C44A-5BED-7A20-E053-F662850A9D86","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"COOPERM","dateModified":"2018-03-14","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983083","version":"1","preferredName":"Pancreatic Tumor Targeted Therapy Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to an individual with pancreatic cancer.","longName":"PANCR_CA_TRG_THR_TP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B68561-0BC1-3C8E-E053-F662850A316E","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-10-01","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983086","version":"1","preferredName":"Pancreatic Disease Increased Risk Prior Clinical History Name","preferredDefinition":"Text term that represents the patient's history of disease that affects the pancreas and may increase risk of pancreatic cancer.","longName":"PANCR_CLIN_HIST_NM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B6BB7C-E15E-3EDE-E053-F662850A893C","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983089","version":"1","preferredName":"SMAD4 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not SMAD4 expression was assessed by immunohistochemistry.","longName":"SMAD4_PRTEXP_IHC_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B72B16-1716-3AB5-E053-F662850AD460","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983161","version":"1","preferredName":"GNAS Gene Mutation Positive Finding Indicator","preferredDefinition":"Indicator of whether or not a GNAS gene mutation was found.","longName":"GNAS_MUT_POS_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B8F3F3-CAB1-1F58-E053-F662850A699B","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983286","version":"1","preferredName":"RNF43 Gene Mutation Positive Finding Indicator","preferredDefinition":"Indicator of whether or not RNF43 mutation was found.","longName":"RNF43_MUT_POS_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B6BB7C-E1AD-3EDE-E053-F662850A893C","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983287","version":"1","preferredName":"SMAD4 Gene Protein Expression Status","preferredDefinition":"Text term that represents the expression status of the SMAD4 protein.","longName":"SMAD4_EXPRN_STS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"59B72B16-1776-3AB5-E053-F662850AD460","latestVersionIndicator":"Yes","beginDate":"2017-09-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-09-21","modifiedBy":"COOPERM","dateModified":"2017-09-30","changeNote":"Created for pancreatic data collection form. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5984832","version":"1","preferredName":"Ewing Sarcoma Targeted Therapy Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to an individual with Ewing's sarcoma.","longName":"5984831v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7F06D0-57E1-7061-E053-F662850A896C","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"COOPERM","dateModified":"2017-10-13","changeNote":"Created for request on 8/21/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001338","version":"1","preferredName":"Karnofsky Performance Status Assessment Event Day Number","preferredDefinition":"Numeric value to represent the day that Karnofsky Performance Status assessment was performed.","longName":"6001337v1.0:2896868v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3B7931-F5F3-5021-E053-F662850A9194","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001339","version":"1","preferredName":"Karnofsky Performance Status Assessment Event Month Number","preferredDefinition":"Numeric value to represent the month that the Karnofsky Performance Status assessment was performed.","longName":"6001337v1.0:2895904v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3BF18C-3EED-5161-E053-F662850A482F","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001340","version":"1","preferredName":"Karnofsky Performance Status Assessment Event Year Number","preferredDefinition":"Numeric value to represent the year that Karnofsky Performance Status assessment was performed.","longName":"6001337v1.0:2896906v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3B545A-04C1-50A8-E053-F662850AD45B","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumor_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001341","version":"1","preferredName":"Eastern Cooperative Oncology Group Performance Status Assessment Event Day Number","preferredDefinition":"Numeric value to represent the day that Eastern Cooperative Oncology Group Performance Status assessment was performed.","longName":"2195004v1.0:2896868v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3B7931-F633-5021-E053-F662850A9194","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001342","version":"1","preferredName":"Eastern Cooperative Oncology Group Performance Status Assessment Event Month Number","preferredDefinition":"Numeric value to represent the month that Eastern Cooperative Oncology Group Performance Status assessment was performed.","longName":"2195004v1.0:2895904v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B383FE9-EEA6-2045-E053-F662850A924C","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001343","version":"1","preferredName":"Eastern Cooperative Oncology Group Performance Status Assessment Event Year Number","preferredDefinition":"Numeric value to represent the year that Eastern Cooperative Oncology Group Performance Status assessment was performed.","longName":"2195004v1.0:2896906v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3C123F-C28F-4C75-E053-F662850A3E42","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001344","version":"1","preferredName":"Karnofsky Performance Status Assessment Date Subtract Biospecimen Collection Date Duration Day Calculation Value","preferredDefinition":"The number of days from the date surgery was performed to acquire the sample to the date that the Karnofsky performance status assessment was performed.","longName":"6001330v1.0:3008213v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3C2A42-994B-5065-E053-F662850A9D1D","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumor_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6001345","version":"1","preferredName":"ECOG - Performance Status Assessment Date Subtract Biospecimen Collection Date Duration Day Calculation Value","preferredDefinition":"The number of days from the date surgery was performed to acquire the sample to the date that the Eastern Cooperative Oncology status assessment was performed.","longName":"6001334v1.0:3008213v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B3B6B8D-F3F0-5857-E053-F662850AD9A3","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-10","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain tumor_10.10.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002200","version":"1","preferredName":"IDH1 Gene Mutation IDH2 Gene Mutation Identification Indicator","preferredDefinition":"The indicator to identify whether an IDH1 or IDH2 mutation was identified at testing.","longName":"6002175v1.0:3506035v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E0CBE-B78A-161C-E053-F662850AB5C2","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"WISEM","dateModified":"2021-02-04","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002201","version":"1","preferredName":"Malignant Neoplasm Susceptibility Genetic Disorder Inherited Type","preferredDefinition":"An inherited genetic mutation that confers heightened susceptibility to cancer.","longName":"6001792v1.0:6001793v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E1CD4-4D71-160D-E053-F662850A7005","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2019-06-24","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002202","version":"1","preferredName":"Histone H3 Lysine 27 Mutation Genotype Results Status","preferredDefinition":"Mutation status of the lysine at position 27 in the histone H3. Histone H3 mutation is often seen in pediatric brain tumors.","longName":"6002117v1.0:3171940v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E2537-33F3-1621-E053-F662850A97BF","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"SPRINGERL","dateModified":"2018-10-12","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002203","version":"1","preferredName":"Laboratory Procedure H3 K27M Mutation Status Immunohistochemistry Laboratory Status","preferredDefinition":"H3F3A K27M mutation assessment by immunohistochemistry is a prognostic marker in some pediatric glioblastomas.","longName":"6002148v1.0:2647941v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E2D67-83F8-682F-E053-F662850ACD60","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002204","version":"1","preferredName":"Gene Mutation Identification Method Other Specify","preferredDefinition":"The method used to determine the precise order of the nucleotides within a DNA molecule that is different from those already specified.","longName":"6002153v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E1CD4-4DB5-160D-E053-F662850A7005","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"COOPERM","dateModified":"2018-08-20","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002205","version":"1","preferredName":"Histone H3 Gene Mutation Identification Type","preferredDefinition":"The mutated histone H3 gene. Mutations in histone H3 are commonly seen in pediatric brain tumors.","longName":"6002156v1.0:6002157v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E3ECC-9038-1609-E053-F662850A26D0","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002206","version":"1","preferredName":"IDH1 IDH2 Gene Mutation Identified Type","preferredDefinition":"Mutations in isocitrate dehydrogenase (IDH) 1 and 2 occur in many low and secondary high grade gliomas. These mutations change the function of IDH enzymes, causing them to switch from producing NADPH to 2-hydroxyglutarate.","longName":"6002175v1.0:6002162v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E2D67-842B-682F-E053-F662850ACD60","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002207","version":"1","preferredName":"IDH1 IDH2 Gene Mutation Identification Other Specify","preferredDefinition":"Mutation identified in IDH1 or IDH2 other than those already specified.","longName":"6002175v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E57C4-CAE1-1605-E053-F662850AC520","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002208","version":"1","preferredName":"Mismatch Repair Gene Mutation Status","preferredDefinition":"The DNA mismatch repair system recognizes and repairs erroneous incorporation of bases that can occur during DNA replication and recombination and in response to DNA damage. Mutations in the mismatch repair system can lead to increased risk of cancer.","longName":"6002179v1.0:6002181v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E602E-7E1F-1601-E053-F662850A10A8","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002209","version":"1","preferredName":"Medulloblastoma Genetic Finding Subclass Category","preferredDefinition":"Stratification of medulloblastoma based on molecular features.","longName":"6002194v1.0:6002185v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E602E-7E5D-1601-E053-F662850A10A8","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"COOPERM","dateModified":"2018-03-14","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6002210","version":"1","preferredName":"Medulloblastoma Genetic Finding Subclass Determination Text","preferredDefinition":"Genetic information used to determine the medulloblastoma subclass.","longName":"6002199v1.0:2666622v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E2537-3425-1621-E053-F662850A97BF","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"HARTLEYG","dateModified":"2017-10-13","changeNote":"Curated to support HCMI Brain Tumors_10.11.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6003729","version":"2","preferredName":"Gene Mutation Identification Method Gene Mutation Identification Method Type","preferredDefinition":"The method used to determine the precise order of the nucleotides within a DNA molecule, often used to identify gene mutations.","longName":"mutation_identification_method","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ED95A83-1E66-6C83-E053-F662850A936B","latestVersionIndicator":"Yes","beginDate":"2017-10-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-07-29","modifiedBy":"HARTLEYG","dateModified":"2019-07-29","changeNote":"Curated to support HCMI Brain Tumors_10.12.17_ghd; versioned due to increase in length and versioning of VD_07.29.19_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6003955","version":"2","preferredName":"Enneking Musculoskeletal Tumor Society System Surgical Grade","preferredDefinition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis._A description of malignant mesenchymal tumors based on cell morphological features._A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis._A position on a scale of intensity or amount or quality.","longName":"6003933v1.1:6003943v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"Enneking SSS/MSTS: Enneking Surgical Staging System adopted by the Musculoskeletal Tumor Society, Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980","workflowStatus":"RELEASED","registrationStatus":"Application","id":"642F6AE6-852A-797C-E053-F662850AD88C","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-01","modifiedBy":"COOPERM","dateModified":"2018-02-16","changeNote":"Created for pediatric osteosarcoma form request 8/21/17. mc Versioned DEC to replace retired Surgical concept per GDC Q12018 dictionary update request 1/30/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6003957","version":"1","preferredName":"Enneking Musculoskeletal Tumor Society Staging System Tumor Stage","preferredDefinition":"Text term and code that represents the tumor site of the musculoskeletal sarcoma, using the Enneking staging system approved by the Musculoskeletal Tumor Society (MSTS).","longName":"6003936v1.0:6003948v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"Enneking SSS/MSTS: Enneking Surgical Staging System adopted by the Musculoskeletal Tumor Society, Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FBD0F-6A31-31BA-E053-F662850ADB49","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-13","modifiedBy":"COOPERM","dateModified":"2018-02-03","changeNote":"Created for pediatric osteosarcoma form request 8/21/17. mc Changed definition and Question Text to add site to describe the tumor stage per GDC Q12018 dictionary update request 1/30/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6003958","version":"1","preferredName":"Enneking Musculoskeletal Tumor Society Staging System Metastasis Stage","preferredDefinition":"Text term and code that represents the metastatic stage of the musculoskeletal sarcoma, using the Enneking staging system approved by the Musculoskeletal Tumor Society (MSTS).","longName":"6003938v1.0:6003951v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"Enneking SSS/MSTS: Enneking Surgical Staging System adopted by the Musculoskeletal Tumor Society, Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FF52E-C882-5D5F-E053-F662850A0B33","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-13","modifiedBy":"COOPERM","dateModified":"2018-02-03","changeNote":"Created for pediatric osteosarcoma form request 8/21/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6005154","version":"1","preferredName":"Rhabdomyosarcoma Targeted Molecular Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to an individual with rhabdomyosarcoma.","longName":"6005152v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BC28C8F-CF75-4FC8-E053-F662850A635C","latestVersionIndicator":"Yes","beginDate":"2017-10-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-17","modifiedBy":"COOPERM","dateModified":"2017-10-25","changeNote":"Created for Rhabdomyosarcoma form request 8/21/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010389","version":"1","preferredName":"Neuroblastoma Targeted Therapy Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to an individual with neuroblastoma.","longName":"6010234v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C5EDBFA-C635-19F2-E053-F662850AA257","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2017-10-25","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010528","version":"1","preferredName":"Neuroblastoma Immunotherapy Administered Regimen Type","preferredDefinition":"Text term that represents the kind of immunotherapy regimen administered to treat neuroblastoma.","longName":"6010286v1.0:2018539v1.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C5D5BA5-6289-19FE-E053-F662850A6077","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2017-10-25","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010754","version":"1","preferredName":"Pediatric Liver Cancer Targeted Therapy Type","preferredDefinition":"Text term that represents a targeted therapy regimen administered to a pediatric patient with liver cancer.","longName":"6010753v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6B6C3F-EA59-4769-E053-F662850AF235","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010765","version":"1","preferredName":"Premature Infant Birth Status Indicator","preferredDefinition":"Indicator of whether or not an infant was born at less than 37 weeks gestation.","longName":"6010757v1.0:6059598v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6C1073-8679-2825-E053-F662850A2D0C","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":"2019-03-06","createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2019-03-11","changeNote":"Created for request 8.21.17 mc  Changed VD to include Not reported. 3.11.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010766","version":"1","preferredName":"Genetic Predisposition Mutation Type","preferredDefinition":"Text term that represents the kind of genetic mutation which increases the risk of cancer.","longName":"6010761v1.0:5873721v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6C1073-86A1-2825-E053-F662850A2D0C","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6013458","version":"1","preferredName":"Genetic Predisposition Syndrome Diagnosis Name","preferredDefinition":"Text term that represents the kind of syndrome diagnosis which increases the risk of cancer.","longName":"6010764v1.0:6013363v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB21E6-3BCB-6E11-E053-F662850ACFBB","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6013618","version":"1","preferredName":"PRETEXT Staging System Primary Childhood Malignant Liver Tumor Stage","preferredDefinition":"Extent of the primary liver tumor prior to treatment using the PRETEXT staging system.","longName":"6013461v1.0:6013463v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CEAD7D1-3F5D-6006-E053-F662850A55AD","latestVersionIndicator":"Yes","beginDate":"2017-11-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-01","modifiedBy":"COOPERM","dateModified":"2018-04-10","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6013641","version":"1","preferredName":"SIOP/COG/NWTSG Staging System Wilms Tumor Stage","preferredDefinition":"Extent of Wilms tumor using the International Society of Paediatric Oncology/Children's Oncology Group/National Wilms' Tumor Study Group staging system.","longName":"6013627v1.0:6013629v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CEF66D4-5CC9-6C59-E053-F662850A48FE","latestVersionIndicator":"Yes","beginDate":"2017-11-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-01","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeNote":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032752","version":"1","preferredName":"Patient Metastatic Malignant Neoplasm Diagnosis Age Day Value","preferredDefinition":"Age at the time of metastasis diagnosis expressed in number of days since birth.","longName":"6032751v1.0:3225625v1.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5EFCE20A-ECB7-36EA-E053-F662850A7E10","latestVersionIndicator":"Yes","beginDate":"2017-11-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-27","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI General CDEs_11.27.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032758","version":"1","preferredName":"Metastatic Lesion Therapy Modality Administered Therapy Modality Type","preferredDefinition":"Text term to identify additional chemotherapy administered after return of disease or metastasis.","longName":"4539790v1.0:6032757v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5EFD40F8-2AAB-365A-E053-F662850A7701","latestVersionIndicator":"Yes","beginDate":"2017-11-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-27","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI General CDEs_11.27.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6032776","version":"1","preferredName":"Microsatellite Instability Analysis Status","preferredDefinition":"The yes/no indicator to signify the status of a tumor for microsatellite instability.","longName":"6029504v1.0:3226958v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5EFE9317-8859-37A6-E053-F662850ADBFE","latestVersionIndicator":"Yes","beginDate":"2017-11-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-27","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support HCMI Colorectal content_11.27.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033148","version":"1","preferredName":"Colorectal Biospecimen Cancer Model Derivation Anatomic Site Biospecimen Anatomic Site Location Name","preferredDefinition":"Text term that represents the anatomic site of the colorectal cancer from which the model was derived.","longName":"6033010v1.0:3242825v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F16072D-F2F9-1D5B-E053-F662850AA3AC","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033149","version":"1","preferredName":"Colorectal Carcinoma Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual.","longName":"6033021v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F162135-F161-4879-E053-F662850AECFD","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033150","version":"1","preferredName":"MLH1 Gene Promoter Methylation Status Indicator","preferredDefinition":"Text term to define the status of promoter methylation for the MLH1 gene.","longName":"6033039v1.0:6033040v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F163C26-CE6C-37AD-E053-F662850A6913","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033151","version":"1","preferredName":"BRAF Gene Expression Immunohistochemical Test Assessment Indicator","preferredDefinition":"The yes/no/unknown indicator to signify whether BRAF expression was assessed by immunohistochemistry.","longName":"6033047v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F164247-65DF-015F-E053-F662850ABA9C","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033152","version":"1","preferredName":"PIK3CA Gene Cytogenetic Analysis Outcome Type","preferredDefinition":"Text term to identify the result of the Mutational analysis and sequencing of the PIK3CA gene.","longName":"6033132v1.0:6033128v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F164755-5FCB-5A59-E053-F662850A33FC","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033153","version":"1","preferredName":"PIK3CA Gene Cytogenetic Analysis Performed Indicator","preferredDefinition":"The yes/no/unknown indicator to signify if PIK3CA gene analysis was performed.","longName":"6033052v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F163C26-CE94-37AD-E053-F662850A6913","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033154","version":"1","preferredName":"PTEN Gene Expression Immunohistochemical Test Assessment Indicator","preferredDefinition":"The yes/no/unknown indicator to signify whether PTEN expression was assessed by immunohistochemistry.","longName":"6033134v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F165834-9569-52C5-E053-F662850A2354","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033155","version":"1","preferredName":"PTEN Gene Expression Cytogenetic Analysis Outcome Status","preferredDefinition":"Text term to identify the result of the expression analysis of the PTEN protein by immunohistochemistry.","longName":"6033140v1.0:6033135v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F165FC8-AA3C-5943-E053-F662850AE351","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033156","version":"1","preferredName":"PTEN Gene Cytogenetic Analysis Performed Indicator","preferredDefinition":"The yes/no/unknown indicator to signify if PTEN gene analysis was performed.","longName":"6033142v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F1664D3-0563-3CDF-E053-F662850ADA81","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6033157","version":"1","preferredName":"PTEN Gene Cytogenetic Analysis Outcome Type","preferredDefinition":"Text term to identify the result of the Mutational analysis and sequencing of the PTEN gene.","longName":"6033144v1.0:6033145v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F1669F6-5166-1FA1-E053-F662850ACDF9","latestVersionIndicator":"Yes","beginDate":"2017-11-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-28","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_11.28.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6036344","version":"1","preferredName":"Colorectal Cancer Venous Invasion Venous Invasion Type","preferredDefinition":"Text term to identify the location of vascular involvement for a tumor.","longName":"2199958v1.0:6036298v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8A8324-BB1E-2321-E053-F662850AE4CC","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Curated to support HCMI Colorectal Content_12.04.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6050944","version":"1","preferredName":"Peripancreatic Lymph Node Examined Count","preferredDefinition":"The total number of peripancreatic lymph nodes tested for the presence of pancreatic cancer cells.","longName":"6050943v1.0:2018392v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"627A799E-EB2F-467F-E053-F662850A555E","latestVersionIndicator":"Yes","beginDate":"2018-01-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-01-11","modifiedBy":"COOPERM","dateModified":"2018-01-18","changeNote":"Created for pancreatic disease group. 1/11/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060079","version":"1","preferredName":"KRAS Gene Mutation Abnormality Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not analysis for KRAS gene mutation abnormality was performed.","longName":"KRAS_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BF0E2-6C49-7C56-E053-F662850A1605","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2018-02-13","changeNote":"Created new unambiguous CDE to replace HCMI reuse of 3123147. 2/5/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060081","version":"1","preferredName":"KRAS Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a KRAS gene mutant protein was identified.","longName":"KRAS_mutation_indicator","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BF7EE-59EB-150C-E053-F662850AE082","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created new unambiguous CDE to replace HCMI reuse of 3123147. 2/5/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060083","version":"1","preferredName":"KRAS Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of KRAS gene mutant protein identified.","longName":"KRAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647C0771-4CAD-77F7-E053-F662850A69DA","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2020-09-16","changeNote":"Created new unambiguous CDE to replace HCMI reuse of 3123147. 2/5/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060279","version":"1","preferredName":"ALK Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of ALK mutant protein identified.","longName":"ALK_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2E72-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061809","version":"1","preferredName":"BRAF Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a mutant protein in the BRAF gene was identified.","longName":"BRAF_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648A50C5-F3C8-1201-E053-F662850AB660","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061810","version":"1","preferredName":"BRAF Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of BRAF gene mutant protein identified.","longName":"BRAF_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648D5A58-9680-09BF-E053-F662850A213A","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061811","version":"1","preferredName":"BRAF Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not BRAF protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"BRAF_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E1D42-A53C-0D42-E053-F662850A7BE2","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061812","version":"1","preferredName":"BRAF Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the BRAF gene protein expression using immunohistochemistry.","longName":"BRAF_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E2E16-F8F5-7FD9-E053-F662850A7378","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061813","version":"1","preferredName":"BRAF Gene Mutation Analysis Performed Indicator","preferredDefinition":"indicator of whether or not an analysis for mutation in the BRAF gene was performed.","longName":"BRAF_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E38D3-E499-4F8B-E053-F662850A49FD","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6061817","version":"1","preferredName":"CD99 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not CD99 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"CD99_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E52D3-BFB3-0C40-E053-F662850AF1E9","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062408","version":"1","preferredName":"IDH1 R132H Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not IDH1 R132H protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"6061877v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491690F-1571-1341-E053-F662850A6B7B","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062409","version":"1","preferredName":"H3 K27M Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not H3 K27M protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"H3_K27M_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64918F62-B0E8-64C7-E053-F662850ACCAE","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062411","version":"1","preferredName":"MLH1 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not MLH1 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"MLH1_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6490E6A6-C48F-5A40-E053-F662850AB029","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062412","version":"1","preferredName":"MSH2 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not MSH2 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"MSH2_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491CB13-B170-4764-E053-F662850AD354","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062413","version":"1","preferredName":"PMS2 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not PMS2 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"PMS2_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491D1FF-3178-65D5-E053-F662850AB817","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062414","version":"1","preferredName":"MSH6 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not MSH6 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"MSH6_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E809-58C8-0F23-E053-F662850A74FF","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062415","version":"1","preferredName":"PTEN Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not PTEN protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"PTEN_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491EAC4-5D34-4BAD-E053-F662850A10E5","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2021-03-03","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062416","version":"1","preferredName":"Estrogen Receptor Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not estrogen receptor (ER) protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"ER_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491334F-6ED9-0F1F-E053-F662850A3EE3","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062504","version":"1","preferredName":"Progesterone Receptor Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not progesterone receptor (PR) protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"PR_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491F8B8-6A6B-1478-E053-F662850AC96F","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062597","version":"1","preferredName":"IDH1 and IDH2 Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not a molecular analysis for IDH1 and IDH2 gene mutation was performed.","longName":"IDH1_IDH2_mutation_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6490C973-8941-60D4-E053-F662850A5885","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062598","version":"1","preferredName":"H3 K27 Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not a molecular analysis for mutation in the lysine residue found at amino acid position 27 in the histone H3 protein (H3 K27) was performed.","longName":"H3_K27_mutation_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64922C96-6A70-0F6F-E053-F662850AE175","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062599","version":"1","preferredName":"Ewing Sarcoma Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not a translocation analysis for Ewing sarcoma was performed.","longName":"Ewing_translocation_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64924FAE-A9F5-6675-E053-F662850AFC19","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063445","version":"1","preferredName":"PIK3CA Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the PIK3CA gene was performed.","longName":"PIK3CA_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491EDB3-335A-1848-E053-F662850A9CB3","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063446","version":"1","preferredName":"PTEN Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the PTEN gene was performed.","longName":"PTEN_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64924FAE-AA1D-6675-E053-F662850AFC19","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063447","version":"1","preferredName":"HER2 FISH or CISH Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not fluorescence in situ hybridization (FISH) or chromogenic in situ hybridization (CISH) analysis for HER2 was performed.","longName":"HER2_FISH_CISH_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6490E6A6-C4B7-5A40-E053-F662850AB029","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063448","version":"1","preferredName":"TP53 Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the TP53 gene was performed.","longName":"TP53_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64938BAF-7C4F-09A8-E053-F662850A9958","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063449","version":"1","preferredName":"CDKN2A Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the CDKN2A gene was performed.","longName":"CDKN2A_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64938BAF-7C77-09A8-E053-F662850A9958","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063450","version":"1","preferredName":"GNAS Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the GNAS gene was performed.","longName":"GNAS_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64913631-2BCE-14D1-E053-F662850A5426","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063451","version":"1","preferredName":"RNF43 Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the RNF43 gene was performed.","longName":"RNF43_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491DA8F-8B5E-16AA-E053-F662850A3CEC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063454","version":"1","preferredName":"HER2 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not HER2 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"HER2_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6493CC44-5A27-02BB-E053-F662850AFF85","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063522","version":"1","preferredName":"Ewing Sarcoma Translocation Identified Indicator","preferredDefinition":"Indicator of whether or not a chromosomal translocation related to Ewing sarcoma was identified.","longName":"Ewing_translocation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A48C44-93AC-614C-E053-F662850AA9B4","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063523","version":"1","preferredName":"TP53 Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a mutant protein in the TP53 gene was identified.","longName":"TP53_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A49197-15E8-0752-E053-F662850A4B0B","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"SARAHB","dateModified":"2020-01-15","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063524","version":"1","preferredName":"PIK3CA Gene Mutation Identified Indicator","preferredDefinition":"Indicator of whether or not a mutation abnormality in the PIK3CA gene was identified.","longName":"PIK3CA_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4963B-4510-4DEF-E053-F662850A0353","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063529","version":"1","preferredName":"PTEN Gene Mutation Identified Indicator","preferredDefinition":"Indicator of whether or not a mutation abnormality in the PTEN gene was identified.","longName":"PTEN_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A49B89-BC92-7ED8-E053-F662850A8100","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063530","version":"1","preferredName":"EGFR Gene Mutation Identified Indicator","preferredDefinition":"Indicator of whether or not a mutation abnormality in the EGFR gene was identified.","longName":"EGFR_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4A0E2-C964-0388-E053-F662850A1448","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063534","version":"1","preferredName":"CDKN2A Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a mutant protein in the CDKN2A gene was identified.","longName":"CDKNA2_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4B7AA-FCCF-09EC-E053-F662850AC257","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063646","version":"1","preferredName":"SMAD4 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not SMAD4 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"SMAD4_immunohistochemistry_ind","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A858D9-F277-67CB-E053-F662850A953A","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063668","version":"1","preferredName":"MLH1 Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the MLH1 gene protein expression using immunohistochemistry.","longName":"MLH1_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2348-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"SOKKERL","dateModified":"2023-05-04","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":"5/4/23:classified and added CTDC ALTname for ECOG/DD. LS","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063669","version":"1","preferredName":"MSH2 Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the MSH2 gene protein expression using immunohistochemistry.","longName":"MSH2_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2370-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063670","version":"1","preferredName":"PMS2 Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the PMS2 gene protein expression using immunohistochemistry.","longName":"PMS2_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2398-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063671","version":"1","preferredName":"MSH6 Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the MSH6 gene protein expression using immunohistochemistry.","longName":"MSH6_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-23C0-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063672","version":"1","preferredName":"PTEN Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the PTEN gene protein expression using immunohistochemistry.","longName":"PTEN_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-23E8-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063673","version":"1","preferredName":"Progesterone Receptor Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the protein expression status of progesterone receptor (PR) using immunohistochemistry.","longName":"PR_protein_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2410-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063674","version":"1","preferredName":"IDH1 (R132H) Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the expression status of a mutation of the IDH1 gene encoding the amino acid substitution Arg132His (R132H) in the isocitrate dehydrogenase [NADP] cytoplasmic protein using immunohistochemistry.","longName":"IDH1_R132H_status","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2438-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063675","version":"1","preferredName":"CD99 Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the CD99 gene protein expression using immunohistochemistry.","longName":"CD99_gene_expression","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-246C-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063676","version":"1","preferredName":"SMAD4 Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the SMAD4 protein expression using immunohistochemistry (IHC).","longName":"SMAD4_protein_expression","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AA9ED3-2494-6D80-E053-F662850A559D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063731","version":"1","preferredName":"TP53 Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of TP53 gene mutant protein identified.","longName":"TP53_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC5B07-1A76-7628-E053-F662850AA377","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063732","version":"1","preferredName":"CDKN2A Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of CDKN2A gene mutant protein identified.","longName":"CDKN2A_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC60B8-5EDD-5301-E053-F662850A1209","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063733","version":"1","preferredName":"GNAS Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of GNAS gene mutant protein identified.","longName":"GNAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC67C4-38BB-78A5-E053-F662850A69A5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063734","version":"1","preferredName":"RNF43 Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of RNF43 gene mutant protein identified.","longName":"RNF43_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC6D0B-1193-714E-E053-F662850A506C","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063735","version":"1","preferredName":"PIK3CA Gene Mutation Exon Identified Type","preferredDefinition":"Text term that represents the  PIK3CA gene exon identified with a mutation.","longName":"PIK3CA_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC7622-E39B-26E7-E053-F662850AFA88","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063736","version":"1","preferredName":"PTEN Gene Mutation Exon Identified Type","preferredDefinition":"Text term that represents the specific exon of the PTEN gene mutation abnormality identified.","longName":"PTEN_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC7622-E3C3-26E7-E053-F662850AFA88","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063955","version":"1","preferredName":"EGFR Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the EGFR gene was performed.","longName":"EGFR_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B9C1B0-4F38-3FAE-E053-F662850AF6CE","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-08","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063959","version":"1","preferredName":"EML4-ALK Translocation Identified Indicator","preferredDefinition":"Indicator of whether or not a EML4-ALK chromosomal translocation was identified.","longName":"EML4_ALK_translocation_identif","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64BA357F-E6D1-4BDC-E053-F662850ADD0A","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-08","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063968","version":"1","preferredName":"EML4-ALK Translocation Exon Identified Type","preferredDefinition":"Text term that represents the specific exon identified with the EML4-ALK chromosomal translocation.","longName":"EML4_ALK_translocation_exon","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64BAA9A3-70AD-6FAD-E053-F662850AC8EF","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-08","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063976","version":"1","preferredName":"EML4-ALK Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the EML4-ALK gene was performed.","longName":"EML4_ALK_translocation_analys","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64BA31BD-F17B-4E12-E053-F662850AB1B7","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-08","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068764","version":"1","preferredName":"Breast Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with breast cancer.","longName":"breast_cancer_targeted_therapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651A3946-C9EF-27BA-E053-F662850ACCEC","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068784","version":"1","preferredName":"Tumor Micropapillary Features Present Status","preferredDefinition":"Text term to identify whether a tumor presents with micropapillary features.","longName":"micropapillary_feature_present","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651AF38C-8C04-25B7-E053-F662850A4F93","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068785","version":"1","preferredName":"Germline Genomic Profile Availability Indicator","preferredDefinition":"Indicator of whether or not the examination and interpretation of sequencing of the genetic material of an organism is available.","longName":"germline_genomics_available","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651AFF57-8C74-2632-E053-F662850A3754","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068786","version":"1","preferredName":"Germline Mutation Nucleotide Sequence Identified Text","preferredDefinition":"Text that describes the germline mutation nucleotide sequence identified.","longName":"germline_mutations_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B0894-7C49-343D-E053-F662850AF7A1","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068787","version":"1","preferredName":"Somatic Mutation Identified Indicator","preferredDefinition":"Indicator of whether or not acquired somatic mutations were identified.","longName":"somatic_mutations_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651AF38C-8C2C-25B7-E053-F662850A4F93","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"BROWNTY","dateModified":"2022-03-07","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6068788","version":"1","preferredName":"Somatic Mutation Nucleotide Sequence Identified Text","preferredDefinition":"Text that describes the somatic mutation nucleotide sequence identified.","longName":"somatic_mutations","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B2210-0F51-2783-E053-F662850AF103","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERJ","dateModified":"2022-04-18","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6069581","version":"1","preferredName":"Genomic Biomarker Performed Indicator","preferredDefinition":"Indicator of whether or not a genomic biomarker test was performed.","longName":"genomic_test_performed","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B567B-C4DD-26A0-E053-F662850AED64","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6069582","version":"1","preferredName":"Genomic Biomarker Test Performed Name","preferredDefinition":"Text term that represents the name of the genomic test performed for cancer.","longName":"genomic_test","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B0894-7C7C-343D-E053-F662850AF7A1","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6069583","version":"1","preferredName":"Other Genomic Biomarker Test Performed Text","preferredDefinition":"Text to specify another genomic test name not previously mentioned.","longName":"other_genomic_test","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B2210-0F79-2783-E053-F662850AF103","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6069584","version":"1","preferredName":"Oncotype Recurrence Score Risk Group Category","preferredDefinition":"Text term that represents the risk group for breast cancer as determined by assessment of the Oncotype recurrence score.","longName":"oncotype_risk_group","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B2210-0FA1-2783-E053-F662850AF103","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6070421","version":"1","preferredName":"MammaPrint Risk Group Category","preferredDefinition":"Text term that represents the risk group for breast cancer as determined by assessment of the MammaPrint test.","longName":"mammaprint_risk_group","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651C0892-9CAD-05D9-E053-F662850AF4B9","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6070422","version":"1","preferredName":"Other Genomic Biomarker Test Risk Group Specify","preferredDefinition":"Text to specify the risk group for breast cancer as determined by assessment of another genomic test.","longName":"other_genomic_test_risk_group","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651BFD87-ADA2-3049-E053-F662850AB613","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeNote":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078871","version":"1","preferredName":"ROS1 FISH Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not FISH analysis of the ROS1 gene was performed.","longName":"ROS1_FISH_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E82149-0512-3A12-E053-F662850AA19F","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078872","version":"1","preferredName":"RET Gene Rearrangement Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not a RET gene rearrangement analysis was performed.","longName":"RET_rearrangement_performed","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E7FC30-30C7-15D5-E053-F662850AA972","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078873","version":"1","preferredName":"PD-L1 Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not PD-L1 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"PDL1_IHC_assessment","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E71C0C-0178-1FD6-E053-F662850A574E","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078874","version":"1","preferredName":"MET Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the MET gene was performed.","longName":"MET_mutation_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E8316B-EDAC-20D4-E053-F662850AE501","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078881","version":"1","preferredName":"ROS1 Rearrangement by FISH Identified Indicator","preferredDefinition":"Indicator of whether or not a ROS1 rearrangement was identified by FISH.","longName":"ROS1_rearrangement_indicator","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E7D365-0F08-6CFA-E053-F662850AFD2E","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078882","version":"1","preferredName":"RET Rearrangement Identified Indicator","preferredDefinition":"Indicator of whether or not a RET rearrangement was identified.","longName":"RET_rearrangement_indicator","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E7189E-27B3-0A6C-E053-F662850ABBC5","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078886","version":"1","preferredName":"MET Gene Mutation Identified Indicator","preferredDefinition":"Indicator of whether or not a mutation abnormality in the MET gene was identified.","longName":"MET_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E6FCBA-8575-0A70-E053-F662850A26B3","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078893","version":"1","preferredName":"Lung Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with lung cancer.","longName":"lung_cancer_targeted_therapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E82149-053A-3A12-E053-F662850AA19F","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078897","version":"2","preferredName":"Lung Cancer Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with lung cancer.","longName":"lung_cancer_immunotherapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DD6BCCB-C62C-631E-E053-F662850AA8A9","latestVersionIndicator":"Yes","beginDate":"2018-06-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-04","modifiedBy":"COOPERM","dateModified":"2018-06-04","changeNote":"Created for Lung request 2.20.18 mc Versioned VD to make it generic for reuse across studies. 6.4.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078901","version":"1","preferredName":"MET Gene Mutation Identified Type","preferredDefinition":"Text term that represents the specific kind of MET gene mutation abnormality identified.","longName":"MET_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65E71148-8E82-0A68-E053-F662850A673F","latestVersionIndicator":"Yes","beginDate":"2018-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-23","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Created for Lung request 2.20.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101680","version":"1","preferredName":"ALK Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another ALK gene mutant protein identified not previously specified.","longName":"other_ALK_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADF7DB-2EBF-5864-E053-F662850A8D70","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101683","version":"1","preferredName":"TP53 Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another TP53 gene mutant protein identified not previously specified.","longName":"other_TP53_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADF184-D6EE-7083-E053-F662850ACC16","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101684","version":"1","preferredName":"CDKN2A Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another CDKN2A gene mutant protein identified not previously specified.","longName":"other_CDKN2A_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADD97C-C6C8-6CD2-E053-F662850A155E","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101685","version":"1","preferredName":"GNAS Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another GNAS gene mutant protein identified not previously specified.","longName":"other_GNAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADD10C-5756-647C-E053-F662850A12D1","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101686","version":"1","preferredName":"RNF43 Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another RNF43 gene mutant protein identified not previously specified.","longName":"other_RNF43_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADD97C-C6F0-6CD2-E053-F662850A155E","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101687","version":"1","preferredName":"BRAF Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another BRAF gene mutant protein identified not previously specified.","longName":"other_BRAF_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADD97C-C718-6CD2-E053-F662850A155E","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COBARRUBIAK","dateModified":"2019-11-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101688","version":"1","preferredName":"PIK3CA Gene Mutation Other Exon Identified Specify","preferredDefinition":"Text term to describe another PIK3CA gene exon identified with a mutation not previously specified.","longName":"other_PIK3CA_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66AE15FC-1924-504B-E053-F662850AC52A","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101689","version":"1","preferredName":"PTEN Gene Mutation Other Exon Identified Specify","preferredDefinition":"Text term to describe another PTEN gene exon identified with a mutation not previously specified.","longName":"other_PTEN_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADC344-8804-2742-E053-F662850A49D3","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101690","version":"1","preferredName":"EML4-ALK Translocation Other Exon Identified Specify","preferredDefinition":"Text term to describe another EML4-ALK gene exon identified with chromosomal translocation not previously specified.","longName":"other_EML4_ALK_translocat_exon","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ADC344-882C-2742-E053-F662850A49D3","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6101691","version":"1","preferredName":"KRAS Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another KRAS gene mutant protein identified not previously specified.","longName":"other_KRAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66AE2904-C84A-3B1A-E053-F662850AC0B8","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeNote":"Created for \"other, specify\" gene id request. 2/26/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119055","version":"1","preferredName":"Adjuvant Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not adjuvant treatment was given.","longName":"adjuvant_therapy_ind","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FEEF39-2C0B-7A71-E053-F662850AF940","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":"12/12/23 Added AQT and alt OID for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119056","version":"1","preferredName":"Adjuvant Therapy Administered Type","preferredDefinition":"Text term that represents the kind of adjuvant treatment given.","longName":"adjuvant_therapy_type","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF44B6-B39F-7BF3-E053-F662850A032D","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"KNABLEJ","dateModified":"2019-04-05","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119057","version":"1","preferredName":"Adjuvant Chemotherapy Administered Type","preferredDefinition":"Text term that represents the kind of adjuvant chemotherapy given to an individual.","longName":"adjuvant_chemotherapy_administ","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF1758-1A7D-0542-E053-F662850ADF2E","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-03-13","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119058","version":"1","preferredName":"Tumor Progression Present Indicator","preferredDefinition":"Indicator of whether or not tumor progression was present.","longName":"progression_at_followup","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FE83FA-F99F-087F-E053-F662850A60D6","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119059","version":"1","preferredName":"Tumor Progression Present Event Day Number","preferredDefinition":"The numeric value to represent the day of tumor progression.","longName":"progression_day_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FE83FA-F9C7-087F-E053-F662850A60D6","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119060","version":"1","preferredName":"Tumor Progression Present Event Month Number","preferredDefinition":"The numeric value to represent the month of tumor progression.","longName":"progression_month_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FEE756-746A-0863-E053-F662850A3F16","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119061","version":"1","preferredName":"Tumor Progression Present Event Year Number","preferredDefinition":"The numeric value to represent the year of tumor progression.","longName":"progression_year_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF62B1-943A-7E55-E053-F662850AD3A3","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119062","version":"1","preferredName":"Recurrent Malignant Neoplasm Present Indicator","preferredDefinition":"Indicator whether or not recurrence was present.","longName":"recurrence_at_followup","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FEEF39-2C33-7A71-E053-F662850AF940","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"SOKKERL","dateModified":"2019-10-15","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119063","version":"1","preferredName":"Metastasis Diagnosis Event Day Number","preferredDefinition":"The numeric value to represent the day of metastasis diagnosis.","longName":"metastasis_day_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF7629-3615-041A-E053-F662850A745B","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119064","version":"1","preferredName":"Metastasis Diagnosis Event Month Number","preferredDefinition":"The numeric value to represent the month of metastasis diagnosis.","longName":"metastasis_month_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF62B1-9462-7E55-E053-F662850AD3A3","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119065","version":"1","preferredName":"Metastasis Diagnosis Event Year Number","preferredDefinition":"The numeric value to represent the year of metastasis diagnosis.","longName":"metastasis_year_number","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FF81FB-3B88-7D67-E053-F662850A887A","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119066","version":"1","preferredName":"Maintenance and/or Consolidation Therapy Administered Prior to Metastatic Tissue Collection Name","preferredDefinition":"Text term that describes the name of the maintanence and/or consolidation therapy administered to an individual prior to metastatic tissue collection.","longName":"maint_consolid_therapy_adminis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FEBBAA-8573-7DD2-E053-F662850A7605","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6119068","version":"1","preferredName":"Metastatic Disease Anatomic Site","preferredDefinition":"Text term that describes the anatomic site of the metastatic disease.","longName":"metastatic_site","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FEE756-7492-0863-E053-F662850A3F16","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132215","version":"1","preferredName":"Progression Subtract First Pathologic Diagnosis Day Calculation Value","preferredDefinition":"Time interval from the date of the initial pathologic diagnosis to the date of tumor progression, represented as a calculated number of days.","longName":"days_to_progression","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67388846-56EA-747E-E053-F662850AC2B2","latestVersionIndicator":"Yes","beginDate":"2018-03-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-12","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132218","version":"1","preferredName":"Metastasis Subtract First Pathologic Diagnosis Day Calculation Value","preferredDefinition":"Time interval from the date of the initial pathologic diagnosis to the date of diagnosis of metastasis, represented as a calculated number of days.","longName":"days_to_metastasis_diagnosis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6738A489-E2BB-0370-E053-F662850A5A01","latestVersionIndicator":"Yes","beginDate":"2018-03-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-12","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6230525","version":"1","preferredName":"MET Gene Other Mutation Abnormality Identified Specify","preferredDefinition":"Text term to describe another MET gene mutation identified not previously specified.","longName":"other_met_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AB0F470-3256-42CB-E053-F662850A34BB","latestVersionIndicator":"Yes","beginDate":"2018-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Created for Lung add-on request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270564","version":"1","preferredName":"Intestinal Tubular Adenocarcinoma Subclass Category","preferredDefinition":"Text term that represents the histologic sub-classification category for tubular (intestinal) adenocarcinoma.","longName":"tubular_adenocarcinoma_subclas","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA56724-D4DF-6756-E053-F662850A2DE3","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Stomach cancer request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270571","version":"1","preferredName":"Stomach Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with stomach cancer.","longName":"stomach_cancer_targeted_therap","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5865D-E719-3C01-E053-F662850ACD46","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Stomach cancer request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270578","version":"1","preferredName":"Stomach Cancer Additional Pathologic Findings Type","preferredDefinition":"Text term that represents significant pathologic finding present in a patient with stomach cancer.","longName":"stomach_cancer_additional_path","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA59194-1F1A-3D31-E053-F662850A6C2B","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for Stomach cancer request 4.19.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326080","version":"1","preferredName":"Ampulla of Vater Adenocarcinoma Histotype Name","preferredDefinition":"Name for the histotype used to refine a diagnosis of Ampulla of Vater Cancer adenocarcinoma.","longName":"adenocarcinoma_histotype","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE68DA1-E0CD-07CD-E053-F662850A3653","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326081","version":"1","preferredName":"Ampulla of Vater Adenocarcinoma with Peculiar Aspect Histotype Name","preferredDefinition":"Name for the subtype used to refine a diagnosis of Ampulla of Vater Cancer adenocarcinoma with peculiar aspects.","longName":"adeno_peculiar_aspects_subtype","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE6A081-A7A1-1A77-E053-F662850A96D6","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326082","version":"1","preferredName":"Ampulla of Vater Neuroendocrine Carcinoma Released Hormone Name","preferredDefinition":"Text name for the hormone(s) released from a well or moderately differentiated neuroendocrine tumor.","longName":"neuroendocrine_tumor_hormone","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE6A081-A7C9-1A77-E053-F662850A96D6","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326083","version":"1","preferredName":"Ampulla of Vater Cancer Hormone Therapy Agent Name","preferredDefinition":"Text term to identify a hormone therapy agent administered to an individual with Ampulla of Vater Cancer.","longName":"AVC_hormone_therapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE6A081-A7F1-1A77-E053-F662850A96D6","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326084","version":"1","preferredName":"Ampulla of Vater Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with Ampulla of Vater cancer.","longName":"AVC_targeted_therapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE56E22-DB00-3444-E053-F662850A39E3","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326085","version":"1","preferredName":"Ampulla of Vater Cancer Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with Ampulla of Vater Cancer.","longName":"AVC_immunotherapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DE6C299-64F2-0819-E053-F662850A4841","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6326086","version":"1","preferredName":"Ampulla of Vater Cancer Tumor Extension Type","preferredDefinition":"Text term to identify the extent to which an Ampulla of Vater tumor has invaded through the wall of an organ into surrounding organs and/or adjacent tissues.","longName":"tumor_extension","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DD89F88-54D0-0ABA-E053-F662850A8614","latestVersionIndicator":"Yes","beginDate":"2018-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-05","modifiedBy":"COOPERM","dateModified":"2018-06-18","changeNote":"Created for Curation request for Ampulla of Vater Cancer 5.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6343812","version":"1","preferredName":"Gene Fusion by RNA or Whole Genome Sequencing or Karyotyping Identification Text","preferredDefinition":"Text description of the gene fusion identified by RNA sequencing, Whole Genome sequencing or karyotype in the patient.","longName":"6341464v1.0:2666622v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FBADEF9-F1E6-66E6-E053-F662850AAEB8","latestVersionIndicator":"Yes","beginDate":"2018-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-28","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for AML CDE request. 6.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6343813","version":"1","preferredName":"Gemtuzumab Ozogamicin Therapy Indicator","preferredDefinition":"Text term that indicates the status of treatment with Gentuzumab ozogamicin.","longName":"6343700v1.0:3506068v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FBA8AD8-521D-7AE1-E053-F662850A6480","latestVersionIndicator":"Yes","beginDate":"2018-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-28","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for AML CDE request. 6.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6343814","version":"1","preferredName":"Refractory Disease Specimen Submission Induction Failure Timepoint Type","preferredDefinition":"Text term that represents the timepoint at which the refractory specimen was submitted for the Induction Failure Project.","longName":"6343789v1.0:2714704v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FBAF023-09B9-3F9F-E053-F662850A655B","latestVersionIndicator":"Yes","beginDate":"2018-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-28","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for AML CDE request. 6.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6379568","version":"1","preferredName":"Therapeutic Procedure Continue Indicator","preferredDefinition":"Indicator of whether or not the patient is still receiving treatment at a follow up point in time.","longName":"Treatment_ongoing","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7236FCC8-7A59-6BE9-E053-F662850A62A0","latestVersionIndicator":"Yes","beginDate":"2018-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-07-30","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"Created for request on 7.25.18 mc","administrativeNotes":"12/12/23 Added alt OID and AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6379572","version":"1","preferredName":"Patient Age on Index Date Day Value","preferredDefinition":"Numeric representation of the patient age on the index date expressed as number of days since birth.","longName":"Index_age","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"72370F31-3369-6B74-E053-F662850A24BE","latestVersionIndicator":"Yes","beginDate":"2018-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-07-30","modifiedBy":"COOPERM","dateModified":"2018-07-30","changeNote":"Created for request on 7.25.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6385020","version":"1","preferredName":"Hormone Therapy Administered Indicator","preferredDefinition":"Indicator of whether or not hormone therapy was administered.","longName":"hormone_tx_admin","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"72E1BE67-D843-3201-E053-F662850A1245","latestVersionIndicator":"Yes","beginDate":"2018-08-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-07","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for request 8.7.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423769","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with either liver or bile duct cancer.","longName":"LIVER_TARGETED_THER","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"752116E9-0969-5A37-E053-F662850AADC4","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423770","version":"1","preferredName":"Hepatocellular Cancer Additional Primary Risk Factor Indicator","preferredDefinition":"An indication as to whether additional primary hepatocellular carcinoma risk factors are documented in the patient's medical record.","longName":"HCC_RISK_FACTOR_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"752116E9-0991-5A37-E053-F662850AADC4","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423771","version":"1","preferredName":"Hepatocellular Cancer Risk Factor Treatment Indicator","preferredDefinition":"An indication as to whether additional hepatocellular carcinoma risk factors have been treated.","longName":"HCC_RISK_TXT_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520A0AC-4058-2159-E053-F662850A7609","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423773","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Additional Pathologic Finding Indicator","preferredDefinition":"An indication as to whether additional pathologic findings are documented in the patient's medical record.","longName":"ADD_PATH_FINDINGS_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520EC4E-8DCC-6530-E053-F662850A1F3F","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423779","version":"1","preferredName":"Bile Duct Cancer Additional Primary Risk Factor History Indicator","preferredDefinition":"An indication as to whether additional primary bile duct cancer risk factors are documented in the patient's medical record.","longName":"BDC_RISK_FACTOR_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7521D55F-680F-5118-E053-F662850A1E83","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423783","version":"1","preferredName":"Viral Hepatitis Sustained Virologic Response Post Treatment Indicator","preferredDefinition":"An indication as to whether sustained virological response was obtained in responses to viral hepatitis treatment.","longName":"VIROLOGICAL_RES_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520A5A9-230E-094A-E053-F662850A3452","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423784","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient.","longName":"ADDTL_PATH_FINDINGS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520A0AC-4080-2159-E053-F662850A7609","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423785","version":"1","preferredName":"Additional Pathologic Investigation Finding Other Specify","preferredDefinition":"Text field for information related to additional pathologic findings that were identified.","longName":"OTHER_PATH_FINDING_SPECIFY","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7521D55F-6837-5118-E053-F662850A1E83","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423786","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Treatment Effect Type","preferredDefinition":"Text term to identify the treatment effect type.","longName":"TREATMENT_EFFECT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520033E-D1A4-2151-E053-F662850A12D0","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423789","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Neoadjuvant Therapy Type","preferredDefinition":"Text term to identify the neoadjuvant therapy type used to treat liver cancer.","longName":"LIVER_CANCER_TXT_TYPE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75219A43-3EBC-42C3-E053-F662850A55EA","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423790","version":"1","preferredName":"Bile Duct Cancer Primary Risk Factor Name","preferredDefinition":"Text term to represent the name of the primary condition that increases a person's chance of developing a malignant tumor of the bile duct.","longName":"BDC_RISK_FACTOR","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"751FDBF0-875C-2149-E053-F662850AF0CC","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423793","version":"1","preferredName":"Bile Duct Cancer Primary Other Risk Factor Name","preferredDefinition":"Text field to describe another primary condition that increases a person's chance of developing a malignant tumor of the bile duct that is not already specified.","longName":"BDC_OTH_RISK_FACTOR","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520EC4E-8DF4-6530-E053-F662850A1F3F","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeNote":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428117","version":"1","preferredName":"Melanoma Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with melanoma.","longName":"melanoma_targeted_therapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757B7F19-0158-4639-E053-F662850AD9AA","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428120","version":"1","preferredName":"Melanoma Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with melanoma.","longName":"melanoma_immunotherapy","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757B6939-7CC1-5586-E053-F662850A58A3","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428122","version":"1","preferredName":"Melanoma Skin Anatomic Site Specify","preferredDefinition":"Text field to specify the location of melanoma growth on the skin.","longName":"skin_site","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757BCC8A-560B-52B4-E053-F662850A64C6","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428123","version":"1","preferredName":"BRAF V600E Immunohistochemistry Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the BRAF V600E mutation was performed.","longName":"BRAF_V600E_IHC_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757BE4EC-06CA-49E7-E053-F662850ACFF7","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428124","version":"1","preferredName":"BRAF V600E Gene Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the BRAF V600E protein expression using immunohistochemistry.","longName":"BRAF_V600E_IHC_EXP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757BEDCB-DD65-4AA5-E053-F662850A75D7","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428125","version":"1","preferredName":"NRAS Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the NRAS gene was performed.","longName":"NRAS_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"757C0C25-C115-5D4E-E053-F662850A4E02","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Curated for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428126","version":"1","preferredName":"NRAS Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a mutant protein in the NRAS gene was identified.","longName":"NRAS_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7578FA10-06F5-60E9-E053-F662850AF6F3","latestVersionIndicator":"Yes","beginDate":"2018-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-09","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429324","version":"1","preferredName":"C-KIT Gene Mutation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the C-KIT gene was performed.","longName":"CKIT_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"758F81B0-C4C7-45A9-E053-F662850A3A98","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-10","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Curated for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429327","version":"1","preferredName":"C-KIT Gene Mutant Protein Identified Indicator","preferredDefinition":"Indicator of whether or not a mutant protein in the C-KIT gene was identified.","longName":"C-KIT_mutation_identified","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"758FAC81-45EF-489F-E053-F662850AADBD","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-10","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429934","version":"1","preferredName":"NRAS Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another NRAS gene mutant protein identified not previously specified.","longName":"other_NRAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75C6D075-41D0-4C7D-E053-F662850A0C11","latestVersionIndicator":"Yes","beginDate":"2018-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-13","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request. 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429935","version":"1","preferredName":"C-KIT Gene Other Mutant Protein Identified Specify","preferredDefinition":"Text term to describe another C-KIT gene mutant protein identified not previously specified.","longName":"other_CKIT_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75C6D550-A34E-4B52-E053-F662850A2249","latestVersionIndicator":"Yes","beginDate":"2018-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-13","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request. 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430530","version":"1","preferredName":"NRAS Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of NRAS gene mutant protein identified.","longName":"NRAS_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7616DF04-82DD-6436-E053-F662850A3EB7","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-17","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8/16/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430531","version":"1","preferredName":"C-KIT Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of C-KIT gene mutant protein identified.","longName":"CKIT_mutation","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7616E534-BABA-0A63-E053-F662850A0EE1","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-17","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeNote":"Created for melanoma request 8/16/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6471217","version":"1","preferredName":"Modified Ryan Scheme for Tumor Regression Score 3 Point Scale","preferredDefinition":"The numeric response using a three-point tumor regression grading system used to measure therapeutic response of the primary tumor and predict patient outcomes.","longName":"MRYAN_TRG_SCL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77BB4EDC-44C0-3C19-E053-F662850A0811","latestVersionIndicator":"Yes","beginDate":"2018-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-10-08","modifiedBy":"HARTLEYG","dateModified":"2019-03-11","changeNote":"Curated to support HCMI Stomach Cancer Data Collection_ghd_10.08.18; Released as part of the quarterly Draft New clean-up_03.11.19_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6501220","version":"1","preferredName":"Birth Date Less Biospecimen Collection Day Calculation Value","preferredDefinition":"Time interval in days from the date of biospecimen collection to the date the patient was born.","longName":"days_to_procurement","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78837C51-9853-099D-E053-F662850AF267","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-19","changeNote":"Created for age at sample procurement CDE request 10.17.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584256","version":"1","preferredName":"Normal Tissue Sample Human Cancer Models Initiative Case Study Collection Count","preferredDefinition":"the number of normal tissue biospecimen samples","longName":"NUM_NORM_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C77865C-622A-49BC-E053-F662850AD66B","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584257","version":"1","preferredName":"Primary Malignant Neoplasm Tissue Sample Human Cancer Models Initiative Case Study Collection Count","preferredDefinition":"the number of primary cancer tissue biospecimen samples","longName":"NUM_PRIMARY_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C786F34-7E87-1D10-E053-F662850A6AC0","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584258","version":"1","preferredName":"Metastatic And/Or Recurrent Malignant Neoplasm Tissue Sample Human Cancer Models Initiative Case Study Collection Count","preferredDefinition":"the number of metastatic/recurrent tissue biospecimen samples","longName":"NUM_MET_REC_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C78748C-0602-2600-E053-F662850AD20D","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584259","version":"1","preferredName":"Other Tissue Sample Human Cancer Models Initiative Case Study Collection Count","preferredDefinition":"the number of other tissue biospecimen samples","longName":"NUM_OTHER_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C7879B9-6A88-1DD4-E053-F662850A89A4","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584264","version":"1","preferredName":"Normal Tissue Sample Sequence Number Identifier","preferredDefinition":"numerical value to represent the sequence count of normal tissue biospecimens","longName":"NUM_SEQ_NORM_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C79DF78-0C0A-1E61-E053-F662850A0284","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584265","version":"1","preferredName":"Primary Malignant Neoplasm Tissue Sample Sequence Number Identifier","preferredDefinition":"numerical value to represent the sequence count of primary cancer tissue biospecimens","longName":"NUM_SEQ_PRIMARY_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C79C52A-D9BE-1E7B-E053-F662850A112B","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584266","version":"1","preferredName":"Metastatic And/Or Recurrent Malignant Neoplasm Tissue Sample Sequence Number Identifier","preferredDefinition":"numerical value to represent the sequence count of metastatic/recurrent tissue biospecimens","longName":"NUM_SEQ_MET_REC_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C79C096-5F9C-1B4E-E053-F662850A58A5","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584267","version":"1","preferredName":"Other Tissue Sample Sequence Number Identifier","preferredDefinition":"numerical value to represent the sequence count of other tissue biospecimens","longName":"NUM_SEQ_OTHER_TIS","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C79DF78-0C32-1E61-E053-F662850A0284","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584268","version":"1","preferredName":"Tumor Disease Anatomic Site Other Specify","preferredDefinition":"text to specify other tissue or organ of primary tumor origin","longName":"PRIMARY_TIS_OTHER","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C777834-780B-2604-E053-F662850A450A","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584270","version":"1","preferredName":"International Classification of Diseases for Oncology, Third Edition Histology Code Specify","preferredDefinition":"text to specify other ICD-O-3 histology code","longName":"ICD-O-3_histology_other","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C79C52A-D9E6-1E7B-E053-F662850A112B","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584271","version":"1","preferredName":"Total Tissue Sample Human Cancer Models Initiative Case Study Collection Count","preferredDefinition":"The number of total tissue biospecimens collected for HCMI for this case","longName":"NUM_TIS_TOTAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C777834-7833-2604-E053-F662850A450A","latestVersionIndicator":"Yes","beginDate":"2018-12-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-07","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.07.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584730","version":"1","preferredName":"Tissue Sample Primary Diagnosis Representation Indicator","preferredDefinition":"Indicator of whether the sample represents the primary diagnosis","longName":"SAMPLE_PRIM_DIAG","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CAEDF46-2D33-582D-E053-F662850AE14F","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584916","version":"1","preferredName":"Other Tissue Sample Cancer Model Anatomic Site Other Specify","preferredDefinition":"the site from which the other tissue used to develop the model was derived not previously listed","longName":"OTHER_TIS_SITE_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CADC94B-B476-4938-E053-F662850A3FD8","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584918","version":"1","preferredName":"Biospecimen Biopathology Center Universally Unique Identifier Identifier","preferredDefinition":"Biopathology center generated unique universal identifier for submitted specimens","longName":"BPC_UUID","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CAEA168-34ED-49F1-E053-F662850A42B8","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6584919","version":"1","preferredName":"Biospecimen Biopathology Center Submitter Identifier","preferredDefinition":"Biopathology center generated identifier for the individual submitting tissue","longName":"BPC_SUBMITTER_ID","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CAF1D6D-34B7-4950-E053-F662850AD1AE","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6586035","version":"1","preferredName":"Tissue Sample Cancer Model Development Center Identifier","preferredDefinition":"text to identify CMDC sample ID","longName":"CMDC_ID_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB14677-C6BC-0968-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6586036","version":"1","preferredName":"Cancer Model Development Center Cancer Model Identifier","preferredDefinition":"text to identify the CMDC model sample ID","longName":"CMDC_MODEL_ID_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB15681-4CB2-0958-E053-F662850A2AAD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-10","modifiedBy":"HARTLEYG","dateModified":"2018-12-18","changeNote":"Curated for HCMI Rare Tumors_12.10.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587389","version":"1","preferredName":"Metastatic And/Or Recurrent Malignant Neoplasm Tissue Sample Collection Method Type","preferredDefinition":"Text term that describes the method of which metastatic/recurrent tumor/cancer tissue is removed from a patient.","longName":"met_specimen_collected_method","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC8830E-67CE-7BE3-E053-F662850AF4CA","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-04","changeNote":"Curated for HCMI Rare Tumors_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587390","version":"1","preferredName":"Metastatic And/Or Recurrent Malignant Neoplasm Tissue Sample Collection Method Other Specify","preferredDefinition":"Text term that describes the method of which metastatic/recurrent tumor/cancer tissue is removed from a patient that was not previously listed.","longName":"met_spec_coll_method_spec","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC81186-A581-0888-E053-F662850A420B","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":"2018-12-11","createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Curated for HCMI Rare Tumors_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587394","version":"1","preferredName":"Metastatic And/Or Recurrent Disease Neoplasm Origin Anatomic Site","preferredDefinition":"Text term that describes the anatomic site of the metastatic and/or recurrent disease.","longName":"metastatic_recurrent_site","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC92809-2837-5230-E053-F662850A7DA8","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-04","changeNote":"Curated for HCMI Rare Tumor_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587395","version":"1","preferredName":"Metastatic And/Or Recurrent Disease or Disorder Anatomic Site Other Specify","preferredDefinition":"Text term that describes the anatomic site of the metastatic and/or recurrent disease not previously listed.","longName":"metas_recur_site_other_spec","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC4D28C-0A2F-081B-E053-F662850A7C26","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Curated for HCMI Rare Tumor_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587398","version":"1","preferredName":"Other Tissue Sample Collection Method Type","preferredDefinition":"Text term that describes the method of which other tissue is removed from a patient.","longName":"other_specimen_collect_method","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC4254C-B3FF-067E-E053-F662850A6FC5","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-04","changeNote":"Curated for HCMI Rare Tumor_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6587399","version":"1","preferredName":"Other Tissue Sample Collection Method Other Specify","preferredDefinition":"Text term that describes the method of which other tissue is removed from a patient not previously listed.","longName":"other_spec_collect_method_spec","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CC9841B-44DE-2A4D-E053-F662850AC3EB","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-11","modifiedBy":"COOPERM","dateModified":"2021-03-10","changeNote":"Curated for HCMI Rare Tumor_ghd_12.11.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6594587","version":"1","preferredName":"Metastatic And/Or Recurrent Malignant Neoplasm Cancer Model Sequence Number Identifier","preferredDefinition":"Numerical value to represent the sequence count of metastatic/recurrent cancer models.","longName":"MET_MODEL_SEQ_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D5073F0-9FA2-72FA-E053-F662850A6923","latestVersionIndicator":"Yes","beginDate":"2018-12-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-18","modifiedBy":"HARTLEYG","dateModified":"2018-12-19","changeNote":"Curated for HCMI Rare Tumors_12.18.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6594590","version":"1","preferredName":"Other Tissue Cancer Model Sequence Number Identifier","preferredDefinition":"Numerical value to represent the sequence count of other cancer models.","longName":"OTH_TIS_MODEL_SEQ_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D5068E3-ED20-72F6-E053-F662850A597B","latestVersionIndicator":"Yes","beginDate":"2018-12-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-18","modifiedBy":"HARTLEYG","dateModified":"2018-12-19","changeNote":"Curated for HCMI Rare Tumors_12.18.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6594596","version":"1","preferredName":"Primary Malignant Neoplasm Cancer Model Sequence Number Identifier","preferredDefinition":"Numerical value to represent the sequence count of primary cancer models.","longName":"PRI_MODEL_SEQ_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D5073F0-9FCD-72FA-E053-F662850A6923","latestVersionIndicator":"Yes","beginDate":"2018-12-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-18","modifiedBy":"HARTLEYG","dateModified":"2018-12-19","changeNote":"Curated for HCMI Rare Tumors_12.18.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6596703","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage Initial Therapy Type","preferredDefinition":"Text term that represents the initial therapy as related to acute leukemia treatment regimens.","longName":"6591121v1.0:6594392v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D65F3F2-B9C6-5AB3-E053-F662850AE88E","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6597003","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage Initial Presentation Category","preferredDefinition":"Text term that represents whether a patient was diagnosed at initial leukemia presentation or only at relapse after an initial leukemia presentation that was not Acute Leukemia of Ambiguous Lineage (ALAL).","longName":"6591136v1.0:6594393v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D65F3F2-BB06-5AB3-E053-F662850AE88E","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6597004","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage World Health Organization Classification Type","preferredDefinition":"Text term that represents the Acute Leukemia of Ambiguous Lineage (ALAL) classification according to World Health Organization (WHO) standards.","longName":"6591138v1.0:6594394v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D65FB4D-C3B2-71F3-E053-F662850AFE2C","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6597005","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm Initial Diagnosis World Health Organization Classification Subtype","preferredDefinition":"Text term that represents the initial diagnosis subtype according to WHO classification of tumors of hematopoietic and lymphoid tissue.","longName":"6591140v1.0:6594394v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D64C68A-1454-234D-E053-F662850A981A","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6597006","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm First Relapse World Health Organization Classification Subtype","preferredDefinition":"Text term that represents the subtype of first relapse according to World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissue.","longName":"6591145v1.0:6594394v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D6866A0-2013-2171-E053-F662850A490D","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6597007","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm Second Relapse World Health Organization Classification Subtype","preferredDefinition":"Text term that represents the subtype of second relapse according to WHO classification of tumors of hematopoietic and lymphoid tissue.","longName":"6591148v1.0:6594394v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D674ABB-9607-22AA-E053-F662850A2B30","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2018-12-19","changeNote":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690668","version":"1","preferredName":"Ovarian Cancer Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual diagnosed with ovarian cancer.","longName":"OVAR_CARC_TGT_TX_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-3981-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690669","version":"1","preferredName":"Ovarian Cancer Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with ovarian cancer.","longName":"OVAR_CARC_IMMUNO_TP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AE3A6-7AFF-39FB-E053-F662850A55C7","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690670","version":"2","preferredName":"Two Level Tumor Grading System Histologic Grade","preferredDefinition":"Text grade for the degree of cellular differentiation in a tissue sample using only two diagnostic categories.","longName":"TWO_LVL_HIST_GRD","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CAE583E3-A913-43C3-E053-4EBD850ACD25","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-08-31","modifiedBy":"HARTLEYG","dateModified":"2021-08-31","changeNote":"Curated to support Ovarian content_Versioned due to versioning of VD_08.31.21_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690671","version":"1","preferredName":"Ovarian Specimen Integrity Status","preferredDefinition":"Text description of the physical condition of the ovarian cancer tumor.","longName":"OVAR_SPEC_INTEG_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AF7E3-B459-3AD8-E053-F662850A0C77","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690672","version":"1","preferredName":"Ovarian Specimen Integrity Status Other Specify","preferredDefinition":"Text description of the physical condition of the ovarian tumor that has not previously mentioned.","longName":"OVAR_SPEC_INTEG_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8648F454-D599-4966-E053-F662850AA087","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690674","version":"1","preferredName":"Ovary Surface Involvement Indicator","preferredDefinition":"The text response regarding whether the surface tissue (outer boundary) of the ovary shows evidence of involvement or presence of cancer.","longName":"OVAR_SURF_INVOLV_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B0C4E-6C78-3FD3-E053-F662850AC5CC","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690678","version":"1","preferredName":"Ovarian Cancer Other Normal Tissue Organ Involvement Other Specify","preferredDefinition":"The text response regarding whether other tissues or organs shows evidence of involvement or presence of ovarian cancer.","longName":"OVAR_OTH_TIS_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8644B35D-A3F4-479A-E053-F662850A762A","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690680","version":"1","preferredName":"Neoplasm Largest External Pelvic Peritoneal Focus Diameter Measurement","preferredDefinition":"The text response that represents the diameter of the largest focus originating outside of the pelvic peritoneal region.","longName":"LG_PER_FOC_DIAM_MSMT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864823D5-62EA-66A2-E053-F662850AACA0","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690681","version":"1","preferredName":"Peritoneal Ascites Cytological Procedure Status","preferredDefinition":"The text response that represents the outcome of cytological analysis for peritoneal/ascitic fluid.","longName":"PER_ASCIT_PROC_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B78ED-8F76-3B26-E053-F662850AA92F","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690682","version":"1","preferredName":"Ovarian Cancer Additional Pathologic Finding Type","preferredDefinition":"Text term that represents other significant pathologic finding present in a patient with ovarian cancer.","longName":"OVAR_ADD_PATH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B81F4-95CB-46CF-E053-F662850AE7B3","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690683","version":"1","preferredName":"Ovarian Cancer Additional Pathologic Finding Other Specify","preferredDefinition":"Text term that represents other significant pathologic finding present in a patient with ovarian cancer not previously listed.","longName":"OVAR_ADD_PATH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86448DEA-377A-5AC4-E053-F662850A7321","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690684","version":"1","preferredName":"Clinical Personal Medical History Disease or Disorder Diagnosis Type","preferredDefinition":"Text term describing a patient's clinical history of prior diseases and/or disorders.","longName":"CLINC_PMHX_DIAGN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8648F454-D5C6-4966-E053-F662850AA087","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690685","version":"1","preferredName":"Clinical Personal Medical History Disease or Disorder Other Specify","preferredDefinition":"Text term describing a patient's clinical history of prior diseases and/or disorders that has not been previously listed.","longName":"CLINC_PMHX_DIS_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B9D35-F66A-6A8B-E053-F662850AEAC9","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690686","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"The text response that indicates whether or not an analysis for mutation in the BRCA1 gene was performed.","longName":"BRCA1_MUT_ANALYS_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86450214-D621-6335-E053-F662850A973B","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690687","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Cytogenetic Analysis Outcome Status","preferredDefinition":"The text response that indicates the type of BRCA1 variant identified as a result of mutational analysis.","longName":"BRCA1_MUT_ANA_OUT_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AE3A6-7B27-39FB-E053-F662850A55C7","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"COOPERM","dateModified":"2019-07-22","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690688","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Cytogenetic Analysis Outcome Specify Text","preferredDefinition":"The text response that indicates the type of BRCA1 variant identified as a result of mutational analysis not previously listed.","longName":"BRCA1_MUT_OUT_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864BC33B-589B-4648-E053-F662850A3D32","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690689","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Molecular Analysis Identification Method Specify Text","preferredDefinition":"Text response that indicates the assay used to identify the BRCA1 mutation.","longName":"BRCA1_MUT_METH_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864BD1AD-53F8-3917-E053-F662850A3AC3","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690690","version":"1","preferredName":"BRCA2 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"The text response that indicates whether or not an analysis for mutation in the BRCA2 gene was performed.","longName":"BRCA2_MUT_ANALYS_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864BD989-ECDF-3802-E053-F662850A7508","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690691","version":"1","preferredName":"BRCA2 Gene Mutation Abnormality Molecular Analysis Outcome Status","preferredDefinition":"The text response that indicates the type of BRCA2 variant identified as a result of mutational analysis.","longName":"BRCA2_MUT_ANA_OUT_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AF7E3-B481-3AD8-E053-F662850A0C77","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690693","version":"1","preferredName":"BRCA2 Gene Mutation Abnormality Molecular Analysis Outcome Specify Text","preferredDefinition":"The text response that indicates the type of BRCA2 variant identified as a result of mutational analysis not previously listed.","longName":"BRCA2_MUT_OUT_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-39A9-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690696","version":"1","preferredName":"Upper Gastrointestinal Endoscopy Gastrointestinal Primary Malignant Neoplasm Negative Finding Performed Indicator","preferredDefinition":"The indication of whether an upper gastrointestinal endoscopy was performed that excluded a gastrointestinal primary malignancy.","longName":"UP_GI_ENDOS_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AE3A6-7B77-39FB-E053-F662850A55C7","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690697","version":"1","preferredName":"Colonoscopy Gastrointestinal Primary Malignant Neoplasm Negative Finding Performed Indicator","preferredDefinition":"The indication of whether an colonoscopy was performed that excluded a gastrointestinal primary malignancy.","longName":"CLNSCPY_GI_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86488CC8-9D16-6496-E053-F662850A27F0","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690699","version":"1","preferredName":"Residual Neoplasm Post Tumor Debulking Status","preferredDefinition":"Text terms to describe the status of a residual neoplasm following tumor debulking.","longName":"RESID_PST_DEBULK_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B8D1C-A8B4-385A-E053-F662850AE284","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690700","version":"2","preferredName":"CA-125 Antigen Baseline Epoch Result Biomarker Value","preferredDefinition":"Numeric value to represent tumor marker CA-125 at baseline.","longName":"CA125_BASELN_RES_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B012E7-109F-589C-E053-4EBD850A8E2B","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-06-22","modifiedBy":"COOPERM","dateModified":"2020-06-22","changeNote":"Curated to support Ovarian content. Increased VD max length to 4 at OCG request and versioned associated CDEs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690702","version":"2","preferredName":"CA-125 Antigen Post Neoadjuvant Chemotherapy Result Biomarker Value","preferredDefinition":"Numeric value to represent tumor marker CA-125 at the end of neoajuvant chemotherapy.","longName":"CA125_PST_CHEMO_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B01D07-D019-5CCB-E053-4EBD850A4E53","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-06-22","modifiedBy":"COOPERM","dateModified":"2020-06-22","changeNote":"Curated to support Ovarian content. Increased VD max length to 4 at OCG request and versioned associated CDEs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690704","version":"2","preferredName":"CA-125 Antigen Post Tumor Debulking Result Biomarker Value","preferredDefinition":"Numeric value to represent tumor marker CA-125 after tumor debulking.","longName":"CA125_PST_DEBULK_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B0409F-0EC8-471B-E053-4EBD850A1366","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-06-22","modifiedBy":"COOPERM","dateModified":"2020-06-22","changeNote":"Curated to support Ovarian content. Increased VD max length to 4 at OCG request and versioned associated CDEs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690705","version":"1","preferredName":"TP53 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not TP53 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"TP53_PRO_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864869A3-A854-6B05-E053-F662850A97D6","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"SARAHB","dateModified":"2020-01-15","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690706","version":"1","preferredName":"PAX8 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the PAX8 mutation was performed.","longName":"PAX8_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8644D850-6CC3-4AF8-E053-F662850AD837","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690712","version":"1","preferredName":"WT1 Gene Gene Expression Process Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the WT1 mutation was performed.","longName":"WT1_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864C3DE8-B675-3D07-E053-F662850A850F","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"COOPERM","dateModified":"2021-03-03","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690713","version":"1","preferredName":"CDKN2A Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the CDKN2A mutation was performed.","longName":"CDKN2A_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864BD989-ED2F-3802-E053-F662850A7508","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690714","version":"1","preferredName":"HNF1A Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the HNF1A mutation was performed.","longName":"HNF1A_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86450214-D649-6335-E053-F662850A973B","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690715","version":"1","preferredName":"CDX2 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the CDX2 mutation was performed.","longName":"CDX2_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864C3A1B-C7F1-3756-E053-F662850A2A8B","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690716","version":"1","preferredName":"KRT7 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the KTR7 mutation was performed.","longName":"KRT7_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B2821-8458-371B-E053-F662850A8FBF","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690717","version":"1","preferredName":"KRT20 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the KTR20 mutation was performed.","longName":"KRT20_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B0746-F30A-3F1E-E053-F662850A827C","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690719","version":"1","preferredName":"TP53 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the TP53 gene protein expression using immunohistochemistry.","longName":"TP53_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864823D5-6312-66A2-E053-F662850AACA0","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690720","version":"1","preferredName":"ESR1 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the ESR1 gene protein expression using immunohistochemistry.","longName":"ESR1_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B0C4E-6CA0-3FD3-E053-F662850AC5CC","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690721","version":"1","preferredName":"PAX8 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the PAX8 gene protein expression using immunohistochemistry.","longName":"PAX8_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864C074E-6A46-400F-E053-F662850AECD6","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690723","version":"1","preferredName":"WT1 Gene Gene Expression Process Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the WT1 gene protein expression using immunohistochemistry.","longName":"WT1_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864A007C-51EA-390F-E053-F662850A746F","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"COOPERM","dateModified":"2021-03-03","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690724","version":"1","preferredName":"CDKN2A Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the CDKN2A gene protein expression using immunohistochemistry.","longName":"CDKN2A_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AF7E3-B4A9-3AD8-E053-F662850A0C77","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-10-24","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690731","version":"1","preferredName":"HNF1A Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the HNF1A gene protein expression using immunohistochemistry.","longName":"HNF1A_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B0C4E-6CC8-3FD3-E053-F662850AC5CC","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690732","version":"1","preferredName":"CDX2 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the CDX2 gene protein expression using immunohistochemistry.","longName":"CDX2_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B4F1A-9B2D-3BA7-E053-F662850AD940","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690733","version":"1","preferredName":"KRT7 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the KTR7 gene protein expression using immunohistochemistry.","longName":"KRT7_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864BD1AD-5448-3917-E053-F662850A3AC3","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690735","version":"1","preferredName":"KRT20 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the KTR20 gene protein expression using immunohistochemistry.","longName":"KRT20_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8644CDA5-91EA-6268-E053-F662850A03A1","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690736","version":"1","preferredName":"BRCA2 Gene Mutation Abnormality Molecular Analysis Identification Method Specify Text","preferredDefinition":"Text response that indicates the assay used to identify the BRCA2 mutation.","longName":"BRCA2_MUT_METH_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864CC15D-CCCC-4491-E053-F662850A2903","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692833","version":"1","preferredName":"Laboratory Procedure CA-125  Performed Indicator","preferredDefinition":"Indicator to signify whether a CA-125 test was performed.","longName":"CA125_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"869A507F-2C1D-7139-E053-F662850A9576","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"TIFFANIS","dateModified":"2019-10-14","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692843","version":"1","preferredName":"Chemotherapy Response Score Treatment Effect 3 Point Scale","preferredDefinition":"The response based on the the original Chemotherapy Response Score assessment that indicates the histopathologic response and prognosis of patients with tubo-ovarian high-grade serous carcinoma (HGSC) receiving neoadjuvant chemotherapy.","longName":"CRS_TRT_EFF_SCALE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"869D7DC2-F237-09AF-E053-F662850AB278","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeNote":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6696813","version":"1","preferredName":"Other Tissue Sample Cancer Model Anatomic Site Name","preferredDefinition":"the anatomic site from which the other tissue used to develop the model was derived.","longName":"OTHER_TISSUE_SITE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86AD7188-9B15-3551-E053-F662850AF68F","latestVersionIndicator":"Yes","beginDate":"2019-04-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-16","modifiedBy":"COOPERM","dateModified":"2021-03-04","changeNote":"Curated for HCMI Rare Tumors and Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788000","version":"1","preferredName":"Head and Neck Carcinoma Targeted Molecular Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with either head or neck cancer.","longName":"HEADNECK_TARGTX_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB31B20-5128-615E-E053-F662850AB30D","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788001","version":"1","preferredName":"Head and Neck Carcinoma Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with head or neck cancer.","longName":"HEADNECK_IMMUNO_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB31BC1-B1FB-6426-E053-F662850A8197","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788002","version":"1","preferredName":"Tumor Extranodal Extension Type","preferredDefinition":"Text term to identify the extent to which a head or neck tumor has invaded into surrounding organs and/or adjacent tissues.","longName":"TUM_EXTNOD_EXT_TYPE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1C33E-E68D-286E-E053-F662850A3139","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788003","version":"1","preferredName":"Endoscopic Mucosal Resection High Grade Dysplasia Present Status","preferredDefinition":"Text term to describe whether high-grade dysplasia has been within the mucosal resection margins.","longName":"RSECT_HIGD_DYSP_STAT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB43BE5-E96F-5F44-E053-F662850A902E","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788004","version":"1","preferredName":"Primary Neoplasm Growth Pattern Type","preferredDefinition":"Text term that indicates the type of growth pattern exhibited by the primary tumor.","longName":"PRI_GROWTH_PAT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB4A-2C18-27A5-E053-F662850AE5E6","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788005","version":"1","preferredName":"Epstein-Barr Virus Early RNA in situ Hybridization Staining Method Performed Indicator","preferredDefinition":"The indication of whether Epstein-Barr Virus early mRNA status was assessed using an in situ hybridization (ISH) assay.","longName":"EBV_MRNA_ISH_PER_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB3B738-15EA-0EB7-E053-F662850A0CEB","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788006","version":"1","preferredName":"Epstein-Barr Virus Early RNA in situ Hybridization Staining Method Status Protein Expression Result","preferredDefinition":"The text response that indicates the Epstein-Barr Virs early mRNA status detected by an in situ hybridization staining method.","longName":"EBV_MRNA_ISH_ST_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB4A-2C40-27A5-E053-F662850AE5E6","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788007","version":"1","preferredName":"Human Papillomavirus DNA in situ Hybridization Staining Method Performed Indicator","preferredDefinition":"The text response indicating whether Human Papillomavirus DNA status was assessed using an in situ hybridization (ISH) assay.","longName":"HPV_DNA_ISH_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB43BE5-E997-5F44-E053-F662850A902E","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788008","version":"1","preferredName":"Human Papillomavirus DNA in situ Hybridization Staining Method Status Protein Expression Result","preferredDefinition":"The text response that indicates the Human Papillomavirus DNA status detected by an in situ hybridization staining method.","longName":"HPV_DNA_ISH_ST_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB4A-2C68-27A5-E053-F662850AE5E6","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788009","version":"1","preferredName":"Human Papillomavirus Transforming Protein E6 E7 mRNA in situ Hybridization Staining Method Performed Indicator","preferredDefinition":"The text response indicating whether Human Papillomavirus E6/E7 status was assessed using an in situ hybridization (ISH) assay.","longName":"HPVE6E7_MRNA_ISH_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB24-B6F1-286A-E053-F662850ADAE5","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788010","version":"1","preferredName":"Human Papillomavirus Transforming Protein E6 E7 mRNA in situ Hybridization Staining Method Status Protein Expression Result","preferredDefinition":"The text response that indicates the Human Papillomavirus E6/E7 mRNA status detected by an in situ hybridization staining method.","longName":"HPVE6E7_MRNA_ISH_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB3343C-3020-5910-E053-F662850A7734","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788011","version":"1","preferredName":"Human Papillomavirus DNA Polymerase Chain Reaction Performed Indicator","preferredDefinition":"The text response that indicates whether or not Human Papillomavirus DNA status was assessed by polymerase chain reaction.","longName":"HPV_DNA_PCR_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB69D01-7B80-5286-E053-F662850A8438","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788012","version":"1","preferredName":"Human Papillomavirus Transforming Protein E6 E7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Performed Indicator","preferredDefinition":"The text response indicating whether Human Papillomavirus E6/E7 mRNA status was assessed using a polymerase chain reaction assay.","longName":"HPVE6E7_MRNA_PCR_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB778FC-5011-1A81-E053-F662850AC467","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788013","version":"1","preferredName":"Alcohol Use Other Specify","preferredDefinition":"The text response that indicates other types of alcohol consumed not previously mentioned.","longName":"ALCOHOL_USE_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB783D0-77CB-0352-E053-F662850AA414","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"TITARENI","dateModified":"2022-01-27","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788015","version":"1","preferredName":"Human Papillomavirus DNA Reverse Transcriptase-Polymerase Chain Reaction Status Result","preferredDefinition":"The text response that indicates the Human Papillomavirus DNA status detected by reverse transcriptase-polymerase chain reaction method.","longName":"HPV_DNA_PCR_PRF_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB7A872-53F8-369C-E053-F662850A9DE1","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788016","version":"1","preferredName":"Human Papillomavirus Transforming Protein E6 E7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Status Result","preferredDefinition":"The text response that indicates the Human Papillomavirus E6/E7 mRNA status detected by reverse transcriptase-polymerase chain reaction method.","longName":"HPVE6E7_PCR_PRF_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB1CB4A-2C90-27A5-E053-F662850AE5E6","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788017","version":"1","preferredName":"Marijuana Current Use Indicator","preferredDefinition":"The test response that indicates whether the patient is currently using marijuana.","longName":"MARIJ_CUR_USE_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB7CC7A-5499-30E3-E053-F662850A51F7","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788018","version":"1","preferredName":"Marijuana Weekly Use Amount Quantity Value","preferredDefinition":"The numeric response that indicates the amount of the patient's marijuana use per week.","longName":"MARIJ_WEEK_USE_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB7DB1E-4466-2DF2-E053-F662850A0233","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788019","version":"1","preferredName":"Electronic Cigarette Greater Than or Equal To 6 Week Regular Use Indicator","preferredDefinition":"The text response that indicates whether a patient has ever used electronic cigarettes regularly for a period of six weeks or more.","longName":"ECIG_GTE_6WK_USE_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB783D0-7829-0352-E053-F662850AA414","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788020","version":"1","preferredName":"Electronic Cigarette Last 30 Day Temporal Frequency Use Number","preferredDefinition":"The numeric response indicating the number of days that the patient used electronic cigarettes within the last 30 days.","longName":"ECIG_30_DY_USE_NUM","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB7F287-A8BF-2B2D-E053-F662850A102E","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788021","version":"1","preferredName":"Head and Neck Carcinoma Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient.","longName":"HDNCK_ADD_PATH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB802A1-C058-2D6C-E053-F662850AD928","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788022","version":"1","preferredName":"Head and Neck Carcinoma Additional Pathologic Finding Other Specify","preferredDefinition":"Text term to describe additional pathologic findings identified in a patient that were not previously listed.","longName":"HDNCK_ADD_PATH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB83DAA-5FD0-2F2E-E053-F662850AD284","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788023","version":"1","preferredName":"Transglottic Extension of Laryngeal Tumor Status Involvement Extent Disease Ind","preferredDefinition":"The text term indicating whether or not a transglottic extension of a laryngeal tumor was present.","longName":"TRNSGLOT_EXT_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB84C05-BBA9-2B4B-E053-F662850ACADA","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788024","version":"1","preferredName":"NUTM1 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not NUTM1 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"NUT_IHC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB802A1-C080-2D6C-E053-F662850AD928","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788025","version":"1","preferredName":"SMARCB1 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the INI-1 gene mutation was performed.","longName":"INI1_IHC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB7A872-5420-369C-E053-F662850A9DE1","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788026","version":"1","preferredName":"MYB Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the MYB gene mutation was performed.","longName":"MYB_IHC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9D14D-AA91-07E2-E053-F662850A2481","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788027","version":"1","preferredName":"AR Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the AR gene mutation was performed.","longName":"AR_IHC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9DA6C-3232-2C8F-E053-F662850A1CAE","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788028","version":"1","preferredName":"NUTM1 Gene Protein Expression Immunohistochemistry Staining Method Status Protein Expression Result","preferredDefinition":"Text term that represents the status of the NUTM1 protein expression using immunohistochemistry.","longName":"NUTM1_EXP_IHC_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-851C-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788029","version":"1","preferredName":"SMARCB1 Gene Protein Expression Immunohistochemistry Staining Method Status Protein Expression Result","preferredDefinition":"Text term that represents the status of the SMARCB1 protein expression using immunohistochemistry.","longName":"SMARCB1_EXP_IHC_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-8544-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788030","version":"1","preferredName":"MYB Gene Protein Expression Immunohistochemistry Staining Method Status Protein Expression Result","preferredDefinition":"Text term that represents the status of the MYB protein expression using immunohistochemistry.","longName":"MYB_EXP_IHC_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-856C-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788031","version":"1","preferredName":"AR Gene Protein Expression Immunohistochemistry Staining Method Status Protein Expression Result","preferredDefinition":"Text term that represents the status of the Androgen Receptor protein expression using immunohistochemistry.","longName":"AR_EXP_IHC_RES","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBA73A7-D429-3295-E053-F662850A37E5","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788032","version":"1","preferredName":"NUTM1 Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the NUTM1 gene was performed.","longName":"NUTM1_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-8594-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788033","version":"1","preferredName":"PAX3 Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the PAX3 gene was performed.","longName":"PAX3_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9D14D-AAB9-07E2-E053-F662850A2481","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788034","version":"1","preferredName":"EWSR1 Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the EWSR1 gene was performed.","longName":"EWSR1_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBAB3D3-BF3C-37E2-E053-F662850AB6D8","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788035","version":"1","preferredName":"ETV6 Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the ETV6 gene was performed.","longName":"ETV6_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-85BC-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788036","version":"1","preferredName":"MAML2 Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the MAML2 gene was performed.","longName":"MAML2_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-85E4-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788037","version":"1","preferredName":"MYB Gene Chromosomal Translocation Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for translocation in the MYB gene was performed.","longName":"MYB_TNLOC_PRFM_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBA73A7-D451-3295-E053-F662850A37E5","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788038","version":"1","preferredName":"NUTM1 Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a NUTM1 chromosomal translocation was identified.","longName":"NUTM1_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-860C-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788039","version":"1","preferredName":"PAX3 Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a PAX3 chromosomal translocation was identified.","longName":"PAX3_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-589D-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788040","version":"1","preferredName":"EWSR1 Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a EWSR1 chromosomal translocation was identified.","longName":"EWSR1_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-58C5-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788041","version":"1","preferredName":"ETV6 Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a ETV6 chromosomal translocation was identified.","longName":"ETV6_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-58ED-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788042","version":"1","preferredName":"MAML2 Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a MAML2 chromosomal translocation was identified.","longName":"MAML2_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-5914-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788043","version":"1","preferredName":"MYB Gene Chromosomal Translocation Identification Indicator","preferredDefinition":"Indicator of whether or not a MYB chromosomal translocation was identified.","longName":"MYB_TNLOC_IDEN_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBAB3D3-BF64-37E2-E053-F662850AB6D8","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788044","version":"1","preferredName":"NUTM1 Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the NUTM1 chromosomal translocation.","longName":"NUTM1_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9D14D-AAE6-07E2-E053-F662850A2481","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788045","version":"1","preferredName":"PAX3 Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the PAX3 chromosomal translocation.","longName":"PAX3_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-593B-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788046","version":"1","preferredName":"EWSR1 Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the EWSR1 chromosomal translocation.","longName":"EWSR1_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-5963-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788047","version":"1","preferredName":"ETV6 Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the ETV6 chromosomal translocation.","longName":"ETV6_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9D14D-AB0E-07E2-E053-F662850A2481","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788048","version":"1","preferredName":"MAML2 Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the MAML2 chromosomal translocation.","longName":"MAML2_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBAB3D3-BF8C-37E2-E053-F662850AB6D8","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788049","version":"1","preferredName":"MYB Gene Chromosomal Translocation Identification Type","preferredDefinition":"Text term that represents the specific exon identified with the MYB chromosomal translocation.","longName":"MYB_TNLOC_IDEN_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-598B-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788050","version":"1","preferredName":"PAX3 Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the PAX3 chromosomal translocation not previously listed.","longName":"PAX3_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB2D12-6EE8-29AD-E053-F662850AE1E9","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788051","version":"1","preferredName":"EWSR1 Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the EWSR1 chromosomal translocation not previously listed.","longName":"EWSR1_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB9EAE5-8634-1927-E053-F662850A003C","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788052","version":"1","preferredName":"ETV6 Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the ETV6 chromosomal translocation not previously listed.","longName":"ETV6_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB2D12-6F10-29AD-E053-F662850AE1E9","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788053","version":"1","preferredName":"MAML2 Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the MAML2 chromosomal translocation not previously listed.","longName":"MAML2_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-59B3-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788054","version":"1","preferredName":"MYB Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the MYB chromosomal translocation not previously listed.","longName":"MYB_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB4299-4CA7-6CE9-E053-F662850A7283","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788055","version":"1","preferredName":"NUTM1 Gene Chromosomal Translocation Identification Other Specify","preferredDefinition":"Text term that represents the specific exon identified with the NUTM1 chromosomal translocation not previously listed.","longName":"NUTM1_TNLOC_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBADC0D-59DB-6315-E053-F662850ACE31","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788056","version":"1","preferredName":"Neoplasm High Grade Transformation Status Involvement Extent Disease Ind","preferredDefinition":"The text response that indicates the high grade transformation status.","longName":"HIGRD_TRFM_ST_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBAB3D3-BFB4-37E2-E053-F662850AB6D8","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788058","version":"1","preferredName":"Mucoepidermoid Carcinoma Neoplasm Histologic Grade Type","preferredDefinition":"The text response that indicates the histologic grade of the Mucoepidermoid carcinoma.","longName":"MUCEP_NEO_HIS_GD_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB6867-52E9-3823-E053-F662850A141B","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788059","version":"1","preferredName":"Salivary Gland Polymorphous Adenocarcinoma Neoplasm Histologic Grade Type","preferredDefinition":"The text response that indicates the histologic grade of the polymorphous adenocarcinoma.","longName":"POLYMORP_HIS_GD_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB4299-4D07-6CE9-E053-F662850A7283","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788060","version":"1","preferredName":"Adenocarcinoma Not Otherwise Specified Neoplasm Histologic Grade Type","preferredDefinition":"The text response that indicates the histologic grade of the adenocarcinoma, NOS.","longName":"ADENOCAR_HIS_GD_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB4299-4D2F-6CE9-E053-F662850A7283","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788061","version":"1","preferredName":"Intraductal Carcinoma of the Minor Salivary Gland Neoplasm Histologic Grade Type","preferredDefinition":"The text response that indicates the histologic grade of the intraductal carcinoma.","longName":"INTRADUCT_HIS_GD_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB735A-C289-7106-E053-F662850AAE0E","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788062","version":"1","preferredName":"Sinonasal Adenocarcinoma Non-Intestinal-Type Neoplasm Histologic Grade Type","preferredDefinition":"The text response that indicates the histologic grade of the non-intestinal adenocarcinoma.","longName":"NONINTEST_HIS_GD_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB8873-036A-78A5-E053-F662850A9EF5","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788063","version":"1","preferredName":"Adenoid Cystic Carcinoma Neoplasm Morphologic Architectural Pattern Type","preferredDefinition":"The text term indicating the morphological pattern of tumor growth for Adenoid cystic carcinoma.","longName":"ADENCYS_GRWTHPAT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBB4299-4D57-6CE9-E053-F662850A7283","latestVersionIndicator":"Yes","beginDate":"2019-06-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-20","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeNote":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790102","version":"1","preferredName":"Kidney Carcinoma Targeted Molecular Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with renal cancer.","longName":"KID_TGT_TX_TYPE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6CE4-2EBE-4EE8-E053-F662850AD874","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790106","version":"1","preferredName":"Kidney Carcinoma Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with renal cancer.","longName":"KID_IMMUNOTX_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A7943-EDCB-4A16-E053-F662850AE725","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790118","version":"1","preferredName":"Rhabdoid Tumor Characteristic Present Involvement Indicator","preferredDefinition":"The indication that histologic features of a rhabdoid component are present.","longName":"RHAB_PRES_DZ_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB8C9-D25B-48E5-E053-F662850A2EA8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Curated to support Renal Cancer content_ghd 7/26/19 Changed VD to use 3151609 with HCMI specific PVs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790119","version":"1","preferredName":"Rhabdoid Tumor Characteristic Present Percentage Value","preferredDefinition":"Numeric value to represent the percentage of the rhabdoid features present in the patient's cancer.","longName":"RHAB_PRES_PCT_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB8C9-D283-48E5-E053-F662850A2EA8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790120","version":"1","preferredName":"Rhabdoid Tumor Characteristic Present Not Specified Indicator","preferredDefinition":"Text response if the percentage of the rhabdoid features present in the patient's cancer was not specified.","longName":"RHAB_PRES_NSPEC_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AD4CF-9EE0-6780-E053-F662850A1BDB","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790121","version":"1","preferredName":"Malignant Neoplasm Necrosis Involvement Indicator","preferredDefinition":"The indication that the histologic feature of tumor necrosis is present.","longName":"NECROSIS_EXT_DZ_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1ADDAD-4CE1-49B1-E053-F662850A5591","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"SOKKERL","dateModified":"2021-05-11","changeNote":"Curated to support Renal Cancer content_ghd 7/26/19 Changed VD to use 3151609 with specific HCMI PVs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790122","version":"1","preferredName":"Malignant Neoplasm Necrosis Percentage Value","preferredDefinition":"Numeric value to represent the percentage of tumor necrosis present in the patient's cancer.","longName":"NECROS_PRES_PCT_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6F76-0B88-4888-E053-F662850A922A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"KUMMEROA","dateModified":"2022-01-10","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790123","version":"1","preferredName":"Malignant Neoplasm Necrosis Not Specified Indicator","preferredDefinition":"Text response if the percentage of the tumor necrosis present in the patient's cancer was not specified.","longName":"NECR_PRES_NSPEC_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C19A8F4-EC53-4DD5-E053-F662850A6BA7","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790124","version":"1","preferredName":"Specimen Histology Sarcomatoid Features Present Percentage Value","preferredDefinition":"Numeric value to represent the percentage of the sarcomatoid features present in the patient's cancer.","longName":"SARCOM_PRES_PCT_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6BD2-840F-4433-E053-F662850ADCC8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790125","version":"1","preferredName":"Specimen Histology Sarcomatoid Features Present Not Specified Indicator","preferredDefinition":"Text response if the percentage of the sarcomatoid features present in the patient's cancer was not specified.","longName":"SARC_PRES_NSPEC_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB4AB-68FE-3207-E053-F662850AC6B8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790126","version":"1","preferredName":"Kidney Carcinoma Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient.","longName":"RENCANC_ADD_PATH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-511B-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790127","version":"1","preferredName":"Kidney Carcinoma Additional Pathologic Finding Cyst Specify","preferredDefinition":"Text term to identify additional pathologic findings of a cyst identified in a patient.","longName":"REN_ADDPATH_CYST_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A4EFB-0382-58F1-E053-F662850A9E4E","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790128","version":"1","preferredName":"Kidney Carcinoma Additional Pathologic Finding Other Specify","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient not previously listed.","longName":"RENCANC_ADDPATH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6F76-0BB0-4888-E053-F662850A922A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790129","version":"1","preferredName":"Kidney Carcinoma Primary Anatomic Site","preferredDefinition":"The text response indicating the primary site of cancer in the kidney.","longName":"RENCAN_PRI_ANTC_SITE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1B2C0C-6100-68B6-E053-F662850A313F","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790130","version":"1","preferredName":"Kidney Carcinoma Primary Anatomic Site Other Specify","preferredDefinition":"The text response indicating the primary site of cancer in the kidney not previously listed.","longName":"RENCAN_PRI_ANTC_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB8C9-D2AB-48E5-E053-F662850A2EA8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790131","version":"1","preferredName":"Kidney Carcinoma Extent Type","preferredDefinition":"Text term to identify the extent to which a kidney tumor has invaded through the wall of an organ into surrounding organs and/or adjacent tissues.","longName":"RENCAN_EXTENT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1ADDAD-4D03-49B1-E053-F662850A5591","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790132","version":"1","preferredName":"Kidney Carcinoma Extent Other Specify","preferredDefinition":"Text term to specify the name of other organs to which a kidney tumor has invaded not previously listed.","longName":"RENCAN_EXTENT_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A133C-536E-3129-E053-F662850A3B70","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790133","version":"1","preferredName":"Circumferential Surgical Margin Resection Type","preferredDefinition":"The text response that indicates the margin type that has been involved by invasive carcinoma.","longName":"SURG_MRG_RES_TYPE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1B7773-8A1E-1485-E053-F662850AAE90","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790134","version":"1","preferredName":"Circumferential Surgical Margin Resection Other Specify","preferredDefinition":"The text response that indicates the margin type that has been involved by invasive carcinoma that has not been previously listed.","longName":"SURG_MRG_RES_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1B7E12-7076-4915-E053-F662850A27CC","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2021-03-04","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790135","version":"1","preferredName":"Non-Neoplastic Kidney Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient's non-neoplastic kidney.","longName":"NON_NEO_KID_PATH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1B8974-1B83-4980-E053-F662850A5ACD","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790136","version":"1","preferredName":"Non-Neoplastic Kidney Additional Pathologic Finding Other Specify","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient's non-neoplastic kidney not previously listed.","longName":"NONNEO_KID_PATH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C195EAC-B12E-5768-E053-F662850AC67A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790137","version":"1","preferredName":"VHL Gene Mutation Abnormality Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the VHL gene was performed.","longName":"VHL_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AAFA9-F72A-6565-E053-F662850AC635","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790138","version":"1","preferredName":"FH Gene Mutation Abnormality Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the FH gene was performed.","longName":"FH_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6F76-0BD8-4888-E053-F662850A922A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790139","version":"1","preferredName":"FLCN Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the FLCN gene was performed.","longName":"FLCN_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C195EAC-B156-5768-E053-F662850AC67A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790140","version":"1","preferredName":"TSC1 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the TSC1 gene was performed.","longName":"TSC1_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C19C3C7-57B4-2E91-E053-F662850A04B1","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790141","version":"1","preferredName":"TSC2 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the TSC2 gene was performed.","longName":"TSC2_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A6BD2-8437-4433-E053-F662850ADCC8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790142","version":"1","preferredName":"BAP1 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the BAP-1 gene was performed.","longName":"BAP1_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A9038-1505-4378-E053-F662850AB49B","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790143","version":"1","preferredName":"SETD2 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the SETD2 gene was performed.","longName":"SETD2_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1B8974-1BAB-4980-E053-F662850A5ACD","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790144","version":"1","preferredName":"PBRM1 Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the PBRM1 gene was performed.","longName":"PBRM1_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A138D-A0D5-2D69-E053-F662850A0C81","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790145","version":"1","preferredName":"SDH Complex Gene Mutation Abnormality Molecular Analysis Performed Indicator","preferredDefinition":"Indicator of whether or not an analysis for mutation in the SDH gene complex was performed.","longName":"SDHCOM_gene_analysis","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1BC776-CDB4-4D53-E053-F662850AAE31","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790146","version":"1","preferredName":"VHL Gene Germline Mutation Identification Indicator","preferredDefinition":"The text response indicating whether a germ-line mutation was identified while performing the VHL gene mutation analysis.","longName":"VHL_GRMLIN_MUT_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A4EFB-03AA-58F1-E053-F662850A9E4E","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"CARTERS","dateModified":"2021-01-21","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790147","version":"1","preferredName":"VHL Gene Germline Mutation Identification Specify","preferredDefinition":"The text response specifying the type of germ-line mutation that was identified while performing the VHL gene mutation analysis.","longName":"VHL_GRMLIN_MUT_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB262-F478-66C8-E053-F662850AF2F1","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790148","version":"1","preferredName":"FH Gene Mutation Abnormality Identification Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the FH gene mutation analysis.","longName":"FH_GENE_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A7943-EDF3-4A16-E053-F662850AE725","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790155","version":"1","preferredName":"FLCN Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the FLCN gene mutation analysis.","longName":"FLCN_GENE_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1BF3C1-2DDE-6627-E053-F662850AE5B7","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790156","version":"1","preferredName":"TSC1 Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the TSC1 gene mutation analysis.","longName":"TSC1_GENE_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1BF812-024B-6875-E053-F662850A0CD9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790157","version":"1","preferredName":"TSC2 Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the TSC2 gene mutation analysis.","longName":"TSC2_GENE_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB8C9-D2D3-48E5-E053-F662850A2EA8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790158","version":"1","preferredName":"BAP1 Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the BAP-1 gene mutation analysis.","longName":"BAP1_GENE_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-5143-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790159","version":"1","preferredName":"SETD2 Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the SETD2 gene mutation analysis.","longName":"SETD2_GEN_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1C1108-2618-6813-E053-F662850A8634","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790160","version":"1","preferredName":"PBRM1 Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the PBRM1 gene mutation analysis.","longName":"PBRM1_GEN_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1C1696-2E84-64BB-E053-F662850A859A","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790161","version":"1","preferredName":"SDHB Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the SDHB gene mutation analysis.","longName":"SDHB_GEN_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AD4CF-9F08-6780-E053-F662850A1BDB","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790162","version":"1","preferredName":"SDHC Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the SDHC gene mutation analysis.","longName":"SDHC_GEN_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1AB8C9-D2FB-48E5-E053-F662850A2EA8","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790163","version":"1","preferredName":"SDHD Gene Mutation Abnormality Identified Indicator","preferredDefinition":"The text response indicating whether a mutation was identified while performing the SDHD gene mutation analysis.","longName":"SDHD_GEN_MUT_ID_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-516B-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790236","version":"1","preferredName":"Gene Mutation Abnormality Identification Type","preferredDefinition":"The text response indicating the type of mutation identified while performing the gene mutation analysis.","longName":"GENE_MUT_ID_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1A138D-A0FD-2D69-E053-F662850A0C81","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"NIKITAP","dateModified":"2022-02-24","changeNote":"Curated to support Renal Cancer content_ghd Modified to make this generic per request by Eva. 7/11/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6790245","version":"1","preferredName":"Gene Mutation Abnormality Identification Specify","preferredDefinition":"The text response indicating the exact type of mutation identified while performing the gene mutation analysis.","longName":"GENE_MUT_ID_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C1BF812-0273-6875-E053-F662850A0CD9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_ghd Modified per Eva request to make the CDE generic for reuse. 7.9.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6815970","version":"1","preferredName":"FLCN Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the FLCN gene mutation abnormality identified.","longName":"FLCN_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5927E2-69EB-574F-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6815971","version":"1","preferredName":"TSC1 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the TSC1 gene mutation abnormality identified.","longName":"TSC1_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D59C620-C7A5-687D-E053-F662850A04BA","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816066","version":"1","preferredName":"TSC2 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the TSC2 gene mutation abnormality identified.","longName":"TSC2_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5B7AA0-864F-1221-E053-F662850A44EF","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816067","version":"1","preferredName":"BAP1 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the BAP1 gene mutation abnormality identified.","longName":"BAP1_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5B7F0B-479D-75BF-E053-F662850ABD42","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816068","version":"1","preferredName":"SETD2 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the SETD2 gene mutation abnormality identified.","longName":"SETD2_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D597F0F-CE8E-5781-E053-F662850A0196","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816069","version":"1","preferredName":"PBRM1 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the PBRM1 gene mutation abnormality identified.","longName":"PBRM1_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D59290F-D8C8-5585-E053-F662850A301F","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816070","version":"1","preferredName":"SDHB Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the SDHB gene mutation abnormality identified.","longName":"SDHB_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5A3054-31E2-5B3A-E053-F662850A3331","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816074","version":"1","preferredName":"SDHC Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the SDHC gene mutation abnormality identified.","longName":"SDHC_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5B9B38-A082-773B-E053-F662850AA8C0","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816075","version":"1","preferredName":"SDHD Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the SDHD gene mutation abnormality identified.","longName":"SDHD_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5B9C75-0EB0-5567-E053-F662850A8CDD","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816076","version":"1","preferredName":"PTEN Gene Mutation Abnormality Identification Specify","preferredDefinition":"Text term that specifies the PTEN gene mutation abnormality identified.","longName":"PTEN_GENE_MUT_ID_SP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5927E2-6A13-574F-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-10","modifiedBy":"COOPERM","dateModified":"2019-07-11","changeNote":"Curated to support Renal Cancer content_mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819511","version":"1","preferredName":"Prostate Carcinoma Hormone Therapy Agent Administered Type","preferredDefinition":"Text term to identify a hormone therapy agent administered to an individual with prostate cancer.","longName":"6819103v1.0:2582816v1.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE193D7-739D-0FFC-E053-F662850AC440","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819512","version":"1","preferredName":"Prostate Carcinoma Targeted Therapy Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with prostate cancer.","longName":"6819105v1.0:5880214v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1A26C-86F0-06DD-E053-F662850AA243","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819519","version":"1","preferredName":"Prostate Carcinoma Immunotherapy Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with prostate cancer","longName":"6819107v1.0:6078830v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1C030-4A50-230F-E053-F662850A2791","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819520","version":"1","preferredName":"Prostate Carcinoma Additional Pathologic Finding Other Specify","preferredDefinition":"Text to describe an additional pathologic finding not previously listed.","longName":"6819109v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1C030-4A78-230F-E053-F662850A2791","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819521","version":"1","preferredName":"Disease Extraprostatic Extension Type","preferredDefinition":"Text term that represents information related to extraprostatic disease extension.","longName":"2192193v1.0:6819349v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1DD76-2685-10A5-E053-F662850ACE02","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819522","version":"1","preferredName":"Bladder Neck Tumor Cell Invasion Indicator","preferredDefinition":"Indicator of whether the urinary bladder neck has been invaded by tumor cells.","longName":"6819112v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1EE93-B0DE-0B5F-E053-F662850A1297","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819523","version":"1","preferredName":"Tumor Margin Involvement Type","preferredDefinition":"Text term that represents information related to margin involvement by invasive carcinoma.","longName":"2010871v2.31:6819465v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1B4EA-FDFF-0B34-E053-F662850AA93F","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819524","version":"1","preferredName":"Infiltrative Tumor Margin Invasion Type","preferredDefinition":"Text term that represents the extent of a tumor border that is invading the adjacent tissue.","longName":"6819115v1.0:6819468v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE14681-21E4-68CF-E053-F662850A0E31","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819525","version":"1","preferredName":"Tertiary Gleason Score for Prostate Cancer Indicator","preferredDefinition":"Indicator of whether a tertiary Gleason Score was identified.","longName":"2782937v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE205E6-1AA7-0EC7-E053-F662850A5327","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819526","version":"1","preferredName":"Intraductal Prostate Carcinoma Involvement Indicator","preferredDefinition":"Text term that represents whether intraductal prostate carcinoma is present.","longName":"6819319v1.0:3151609v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE20CFA-63E2-5FFA-E053-F662850AAA0B","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":"11/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819528","version":"1","preferredName":"Benign Prostatic Hyperplasia Treatment Administered Indicator","preferredDefinition":"Indicator of whether a patient was treated for benign prostatic hyperplasia.","longName":"6819321v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE205E6-1ACF-0EC7-E053-F662850A5327","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819529","version":"1","preferredName":"Benign Prostatic Hyperplasia Treatment Administered Type","preferredDefinition":"Text term that represents the kind of treatment administered for benign prostatic hyperplasia.","longName":"6819321v1.0:6819500v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE21BD2-C8E8-1B7A-E053-F662850AD205","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819530","version":"1","preferredName":"Benign Prostatic Hyperplasia Other Treatment Administered Specify","preferredDefinition":"Text to describe another kind of treatment for benign prostatic hyperplasia not previously listed.","longName":"6819324v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE1272E-8730-5D2A-E053-F662850AF481","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819569","version":"1","preferredName":"Primary Tumor Diagnostic Imaging Performed Indicator","preferredDefinition":"Indicator of whether imaging (beyond ultrasound) was used in diagnosis of the primary tumor.","longName":"6819327v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE2850C-0B2C-06B4-E053-F662850A566A","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819575","version":"1","preferredName":"Primary Tumor Identification Subsequent Diagnostic Imaging Indicator","preferredDefinition":"Indicator of whether the primary tumor was identified in subsequent imaging evaluation.","longName":"6819330v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE6A710-DD6F-0AF1-E053-F662850A0A78","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819576","version":"1","preferredName":"Primary Tumor Subsequent Evaluation Imaging Technique Type","preferredDefinition":"Text term that represents the imaging method used to identify the primary tumor in subsequent evaluation.","longName":"6819341v1.0:3178305v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE222CF-F246-6AF1-E053-F662850AC45E","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819581","version":"1","preferredName":"Positron Emission Tomography Tracer Type","preferredDefinition":"Text term that represents the kind of tracer used in Positron Emission Tomography (PET) imaging.","longName":"6819345v1.0:6819501v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE2E8DC-2734-0AD7-E053-F662850AF28D","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819582","version":"1","preferredName":"Positron Emission Tomography Other Tracer Specify","preferredDefinition":"Text that describes another tracer used for positron emission tomography (PET) imaging not otherwise listed.","longName":"6819348v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE727CB-0326-51E0-E053-F662850A7C65","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819586","version":"2","preferredName":"Metastatic Tumor Diagnostic Imaging Performed Type","preferredDefinition":"Text term that represents the kind of imaging used to identify the metastatic tumor.","longName":"6819584v1.0:2201767v1.1","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D918A7EF-4590-5042-E053-4EBD850A3F9D","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-28","modifiedBy":"KUMMEROA","dateModified":"2022-02-28","changeNote":"2022-2-28 ak Versioned due to VD1.1  version association. Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819588","version":"1","preferredName":"Primary Tumor Diagnostic Imaging Performed Type","preferredDefinition":"Text term that represents the kind of imaging used to diagnose the primary tumor.","longName":"6819327v1.0:3178305v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE76CB3-707E-5326-E053-F662850A3D37","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819607","version":"1","preferredName":"Primary Tumor Other Diagnostic Imaging Method Specify","preferredDefinition":"Text that describes another imaging method used in the diagnosis of the primary tumor not otherwise listed.","longName":"6819604v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE2850C-0B54-06B4-E053-F662850A566A","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819611","version":"1","preferredName":"Metastatic Tumor Other Diagnostic Imaging Method Specify","preferredDefinition":"Text term to describe another imaging method used to diagnose the metastatic tumor.","longName":"6819606v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE789F5-38A4-171E-E053-F662850ACC79","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819618","version":"1","preferredName":"Prostate Carcinoma Treatment Effect Type","preferredDefinition":"Text term that represents the effect of treatment for prostate cancer.","longName":"6819614v1.0:6819471v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE76CB3-70A6-5326-E053-F662850A3D37","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819619","version":"1","preferredName":"Prostate Carcinoma Other Treatment Effect Specify","preferredDefinition":"Text term to describe another treatment effect for prostate cancer not otherwise listed.","longName":"6819617v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DE2E8DC-275F-0AD7-E053-F662850AF28D","latestVersionIndicator":"Yes","beginDate":"2019-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-17","modifiedBy":"COOPERM","dateModified":"2019-07-26","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819981","version":"1","preferredName":"Metastatic Tumor Imaging Positive Prior to Biopsy  Indicator","preferredDefinition":"Indicator of whether the metastatic tumor site was positive by imaging prior to biopsy.","longName":"6819645v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45713B-D085-668B-E053-F662850ABE8D","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819986","version":"1","preferredName":"Circulating Tumor Cell Test Result Indicator","preferredDefinition":"Indicator of whether circulating tumor cells are present or absent.","longName":"6819711v1.0:6033040v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E458511-9FB3-7251-E053-F662850AD0A4","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819987","version":"1","preferredName":"Decipher Prostate Cancer Test Score","preferredDefinition":"Numeric representation of the score for the Decipher prostate cancer test.","longName":"6819714v1.0:6819737v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E459449-630C-6677-E053-F662850A3BEC","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819988","version":"1","preferredName":"Oncotype DX Genomic Prostate Score Risk Group Category","preferredDefinition":"Text term that represents the risk group based on the Oncotype DX Genomic Prostate test score.","longName":"6819717v1.0:6819738v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E459E71-1840-37DF-E053-F662850ADC85","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"ZHWENDY","dateModified":"2022-07-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":"7/19/2022: fixed the box symbol in PQT.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6819989","version":"1","preferredName":"Prolaris Molecular Prostate Cancer Testing Score","preferredDefinition":"Numeric representation of the Prolaris prostate cancer test result.","longName":"6819720v1.0:6819739v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45AF33-D152-5C9B-E053-F662850AB987","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820003","version":"1","preferredName":"ProMark Proteomic Prognostic Test Risk Score","preferredDefinition":"Numeric representation of the ProMark Proteomic Prognostic test risk score.","longName":"6819723v1.0:6819740v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E459449-6334-6677-E053-F662850A3BEC","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820004","version":"1","preferredName":"Mutational Analysis Tissue Submission Type","preferredDefinition":"Text term that represents the kind of tissue submitted for mutational analysis.","longName":"6819726v1.0:3111295v1.2","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45D0ED-A55C-7C15-E053-F662850A362F","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820011","version":"1","preferredName":"Mutational Analysis Other Tissue Submission Specify","preferredDefinition":"Text term that describes another kind of tissue submitted for mutational analysis that was not previously listed.","longName":"6819729v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E459E71-1868-37DF-E053-F662850ADC85","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820015","version":"1","preferredName":"ATM Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the ATM gene mutation abnormality identified.","longName":"6005209v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45EED3-522E-08BB-E053-F662850A0499","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820016","version":"1","preferredName":"PALB2 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the PALB2 gene mutation abnormality identified.","longName":"6819732v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45EED3-5256-08BB-E053-F662850A0499","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820017","version":"1","preferredName":"FANCA Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the FANCA gene mutation abnormality identified.","longName":"6819734v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E461EEC-2C49-6693-E053-F662850A6B23","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820020","version":"1","preferredName":"FH Gene Mutation Abnormality Identification Specify","preferredDefinition":"Text term that specifies the FH gene mutation abnormality identified..","longName":"6820019v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E45079E-6A9D-6687-E053-F662850A674D","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-07-22","changeNote":"Created for renal request mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820021","version":"1","preferredName":"PALB2 Gene Mutation Abnormality Identification Indicator","preferredDefinition":"Indicator of whether or not a mutation in the PALB2 gene was identified.","longName":"6819732v1.0:3506068v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E46858C-9431-7357-E053-F662850AC2AC","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820022","version":"1","preferredName":"FANCA Gene Mutation Abnormality Identification Indicator","preferredDefinition":"Indicator of whether or not a mutation in the FANCA gene was identified.","longName":"6819734v1.0:3506068v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E468AC5-54D3-699D-E053-F662850A1EF1","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820040","version":"1","preferredName":"Mutational Analysis Performed Gene Type","preferredDefinition":"Text term that represents the kind of gene that was tested using mutational analysis.","longName":"3193821v1.0:5873721v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4695DE-EA11-6CE3-E053-F662850A8E60","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6820057","version":"1","preferredName":"Protein Expression Immunohistochemistry Staining Method Performed Gene Type","preferredDefinition":"The kind of protein expression that was tested using immunohistochemical (IHC) staining.","longName":"6819736v1.0:5873721v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E461EEC-2C71-6693-E053-F662850A6B23","latestVersionIndicator":"Yes","beginDate":"2019-07-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-22","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821457","version":"1","preferredName":"Circulating Tumor Cell AR-V7 Performed Indicator","preferredDefinition":"Indicator of whether or not AR-V7 was tested in circulating tumor cells.","longName":"6821421v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4BD309-BDAF-46F0-E053-F662850AAEB0","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821463","version":"1","preferredName":"Circulating Tumor Cell AR-V7 Result Indicator","preferredDefinition":"Indicator of whether or not circulating tumor cells were present.","longName":"6821430v1.0:6033040v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4A3450-8162-3694-E053-F662850AE1C8","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821464","version":"1","preferredName":"AR-V7 RNA In Situ Hybridization Performed Indicator","preferredDefinition":"Indicator of whether or not in situ hybridization for AR-V7 RNA (RISH) was performed?","longName":"6821433v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4CCA08-F1F1-608C-E053-F662850AC3C8","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821465","version":"1","preferredName":"AR-V7 RNA in situ Hybridization Result","preferredDefinition":"Text term that represents the result of AR-V7 RNA testing by in situ hybridization.","longName":"6821436v1.0:6828123v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4C64F9-F66F-4EF6-E053-F662850A149C","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821476","version":"1","preferredName":"AR-V7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Performed Indicator","preferredDefinition":"Indicator of whether AR-V7 messenger RNA Reverse Transcriptase-Polymerase Chain Reaction was performed.","longName":"6821441v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4CCA08-F21A-608C-E053-F662850AC3C8","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821477","version":"1","preferredName":"AR-V7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Result","preferredDefinition":"Text term that represents the result of the AR-V7 messenger RNA Reverse Transcriptase-Polymerase Chain Reaction  test.","longName":"6821447v1.0:6788014v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4BD309-BDD7-46F0-E053-F662850AAEB0","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6821495","version":"1","preferredName":"AR-V7 Protein Expression by Immunohistochemical Test Result","preferredDefinition":"Text term that represents the AR-V7 protein expression result of the immunohistochemical test.","longName":"6821456v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4CCF1B-4B88-3C7C-E053-F662850A3923","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6826926","version":"1","preferredName":"Tertiary Gleason Grade Pattern 4 or 5 Percent Category","preferredDefinition":"Text term that represents the pattern of the Gleason Tertiary Grade when the Gleason Score is greater than 7.","longName":"2782937v1.0:6826923v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E82DFFB-9E60-24A9-E053-F662850ADA38","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6826927","version":"1","preferredName":"Tertiary Gleason Grade Pattern 4 or 5 Percent Value","preferredDefinition":"Numeric value for the percent of Gleason pattern 4 or 5 when the Gleason Score is greater than 7.","longName":"2782937v1.0:2903088v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E82E8B2-1B97-55FF-E053-F662850AD616","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6829555","version":"1","preferredName":"Circulating Tumor Cell Laboratory Procedure Performed Indicator","preferredDefinition":"Indicator of whether the presence of circulating tumor cells (CTCs) was tested?","longName":"6829548v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E85EB61-DF85-3703-E053-F662850A4A3D","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6831339","version":"1","preferredName":"Prostatic Tissue Estimated Tumor Involvement Percentage Value","preferredDefinition":"Numeric representation of the estimated percentage of prostatic tissue involved by tumor.","longName":"6829700v1.0:2903088v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E85CB4E-2240-71E7-E053-F662850A80C0","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"HARTLEYG","dateModified":"2019-09-23","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6831608","version":"1","preferredName":"Tumor Dominant Nodule Dimension Measurement","preferredDefinition":"Numeric value in millimeters for the size of the dominant (if present) tumor nodule.","longName":"6831558v1.0:6831368v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E878E89-072D-7320-E053-F662850A4CFB","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"HARTLEYG","dateModified":"2019-09-23","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6831609","version":"1","preferredName":"Tumor Additional Dimension Measurement","preferredDefinition":"Numeric value in millimeters for an additional dimension of the tumor.","longName":"6831569v1.0:6831368v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E87D049-5929-18C3-E053-F662850ACBAE","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-25","modifiedBy":"HARTLEYG","dateModified":"2019-09-23","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6832296","version":"1","preferredName":"CHEK2 Gene Mutation Abnormality Identification Specify","preferredDefinition":"Text term that represents the specific kind of CHEK2 gene mutation abnormality identified.","longName":"6831575v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E97D494-BDD4-034E-E053-F662850A86BB","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-26","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6832443","version":"1","preferredName":"Primary Malignant Neoplasm Next Evaluation Imaging Technique Other Specify","preferredDefinition":"Text term that describes another imaging method(s) used to identify the primary tumor in subsequent evaluation not previously listed.","longName":"6819341v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E99D9FE-71F1-4476-E053-F662850ABF20","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-26","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6840947","version":"1","preferredName":"HOXB1 Gene Mutation Abnormality Identification Indicator","preferredDefinition":"Indicator of whether or not a mutation in the HOXB1 gene was identified.","longName":"6840929v1.0:3506068v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE8F9A4-B121-6466-E053-F662850A3FF7","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-30","modifiedBy":"COOPERM","dateModified":"2019-07-30","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6840948","version":"1","preferredName":"HOXB1 Gene Mutation Abnormality Identified Specify","preferredDefinition":"Text term that specifies the HOXB1 gene mutation abnormality identified.","longName":"6840929v1.0:2556910v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE83ECB-AA33-7371-E053-F662850A5F61","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-30","modifiedBy":"HARTLEYG","dateModified":"2019-09-24","changeNote":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6941877","version":"1","preferredName":"Mitotic Count Rate","preferredDefinition":"The numeric response that indicates the rate measured for the number of mitoses identified under the microscope in malignant neoplasm.","longName":"MIT_COUNT_RATE","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C7F513-FD20-70EA-E053-F662850A0C6A","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeNote":"Curated to support Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6941879","version":"1","preferredName":"Neuroendocrine Tumor Functional Assessment Status","preferredDefinition":"The response that indicates the neuroendocrine tumor status.","longName":"NROEND_TMR_FNL_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C78A3E-6EA4-4FC0-E053-F662850A0F3D","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2020-02-04","changeNote":"Curated to support Neuroendocrine Tumor - Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6941881","version":"1","preferredName":"Neuroendocrine Neoplasm Present Type","preferredDefinition":"The text response that indicates the type of pancreatic neuroendocrine tumor present.","longName":"NROEND_TMR_PST_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C80BAF-04F2-6E04-E053-F662850AE488","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeNote":"Curated to support Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6941882","version":"1","preferredName":"Neuroendocrine Neoplasm Present Other Specify","preferredDefinition":"The text response that indicates the type of neuroendocrine tumor present that was not previously listed.","longName":"NROEND_TMR_OTH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C7595D-169F-595C-E053-F662850A219D","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeNote":"Curated to support Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942918","version":"1","preferredName":"Androgen Suppression Therapy Administration Specify Text","preferredDefinition":"The text that specifies the androgen therapy that was administered.","longName":"ADGN_SUP_TX_ADM_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93018737-826E-1B21-E053-F662850A3CCC","latestVersionIndicator":"Yes","beginDate":"2019-09-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-20","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeNote":"Curated to support the Head and Neck Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7024271","version":"1","preferredName":"Perimetrium Disease or Disorder Involvement Indicator","preferredDefinition":"The response indicating whether or not the uterine serosa (perimetrium) is involved in the disease.","longName":"7024270v1.0:2846999v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9597B9EA-B11A-7F7F-E053-F662850AB6AA","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support HCMI Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028259","version":"1","preferredName":"Endometrial Carcinoma Hormone Therapy Agent Type","preferredDefinition":"Text term to identify a hormone therapy agent administered to an individual with endometrial cancer.","longName":"EDMTR_HORM_AGT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C30374-3953-3F78-E053-F662850AEA18","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028260","version":"1","preferredName":"Endometrial Carcinoma Targeted Therapy Agent Type","preferredDefinition":"Text term to identify a targeted molecular therapy agent administered to an individual with endometrial cancer.","longName":"EDMTR_TGTX_AGT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C0BAAE-1F75-7ADE-E053-F662850AE129","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028261","version":"1","preferredName":"Endometrial Carcinoma Immunotherapeutic Agent Type","preferredDefinition":"Text term to identify an immunotherapy agent administered to an individual with endometrial cancer.","longName":"EDMTR_IMMUNO_AGT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4A281-998A-6231-E053-F662850AF6C9","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028262","version":"1","preferredName":"Endometrial Carcinoma FIGO Histopathologic Grade","preferredDefinition":"The grade representing the extent of endometrial cancer in the body, based on staging criteria from the Federation of Gynecology and Obstetrics (FIGO).","longName":"EDMTR_FIGO_HX_GD","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C30A7B-4FC1-3F74-E053-F662850A657F","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028263","version":"1","preferredName":"Endometrial Carcinoma FIGO Histologic Grade Other Specify","preferredDefinition":"The grade representing the extent of endometrial cancer in the body, based on staging criteria from the Federation of Gynecology and Obstetrics (FIGO) not previously listed.","longName":"EDMTR_FIGO_HX_GD_SPC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C3325A-48C7-3F88-E053-F662850A4A90","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028264","version":"1","preferredName":"Specimen Integrity Type Specify Text","preferredDefinition":"Text description of the physical condition of the specimen.","longName":"SPC_ITGT_TYP_SPC_TXT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-314A-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028265","version":"1","preferredName":"Myometrial Invasion Depth Float","preferredDefinition":"The numeric response that indicates the depth of invasion of the myometrium by cancer.","longName":"MYOMT_INV_DPT_FL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C3325A-48EF-3F88-E053-F662850A4A90","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028266","version":"1","preferredName":"Myometrium Thickness Measurement","preferredDefinition":"The numeric response that indicates the thickness of the smooth muscle lining of the uterus.","longName":"MYOMT_THICK_MMT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-3172-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028267","version":"1","preferredName":"Uterine Corpus Adenomyosis Assessment Finding Status","preferredDefinition":"The response indicating whether or not the growth of endometrial tissue inside the muscular wall of the uterine corpus is involved with endometrial cancer.","longName":"UTCOR_ADEN_FIND_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4CF3D-9FE6-63FC-E053-F662850A8EA9","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028268","version":"1","preferredName":"Isthmus Uteri Assessment Finding Status","preferredDefinition":"The response indicating the status of whether the isthmus uteri has been involved with endometrial cancer.","longName":"ISTH_UTR_FIND_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4CF3D-A00E-63FC-E053-F662850A8EA9","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028269","version":"1","preferredName":"Cervix Uteri Stromal Cell Assessment Finding Status","preferredDefinition":"The response indicating whether or not the cervix uteri stromal cells are involved with endometrial cancer.","longName":"CRVX_UTR_STRM_CL_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C0BAAE-1F9E-7ADE-E053-F662850AE129","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028270","version":"1","preferredName":"Pelvic Lymph Node Assessment Finding Status","preferredDefinition":"The response indicating the status of whether the pelvic lymph nodes have been involved with endometrial cancer.","longName":"PLVLN_FIND_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C2D8FB-4D67-3F80-E053-F662850ABFC8","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028278","version":"1","preferredName":"Endometrial Carcinoma Additional Pathologic Findings Type","preferredDefinition":"The response indicating any additional pathological findings identified.","longName":"EDMTR_ADD_PTH_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4EA3B-A791-60D8-E053-F662850AB208","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028279","version":"1","preferredName":"Endometrial Carcinoma Additional Pathologic Findings Other Specify","preferredDefinition":"The response indicating any other additional pathological findings identified not previously listed.","longName":"EDMTR_APTH_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-31C2-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028280","version":"1","preferredName":"Clinical Personal Medical History Other Malignant Neoplasm Disease or Disorder Other Specify","preferredDefinition":"Text term describing a patient's clinical history of prior cancer diagnoses not previously listed.","longName":"MHX_MLGNT_DZ_OT_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C36BCC-6F92-3F7C-E053-F662850AC79A","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":"2019-10-28","createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028281","version":"1","preferredName":"PIK3CA Gene Mutation Abnormality Identification Type","preferredDefinition":"The response indicating the gene mutation identified for the PIK3CA gene.","longName":"PIK3CA_GN_MUT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C2F80F-DDE7-3F84-E053-F662850AF900","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028282","version":"1","preferredName":"PIK3CA Gene Mutation Abnormality Identification Other Specify","preferredDefinition":"The response indicating the gene mutation identified for the PIK3CA gene not previously listed.","longName":"PIK3CA_MUT_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C2F80F-DE0F-3F84-E053-F662850AF900","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028283","version":"1","preferredName":"Oral Contraceptive Use Pre-study Indicator","preferredDefinition":"The response that indicates whether or not a patient has previously used oral contraceptives.","longName":"ORL_CNPT_USE_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C2F80F-DE37-3F84-E053-F662850AF900","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028284","version":"1","preferredName":"Oral Contraceptive Agent Type","preferredDefinition":"The response that indicates the type of oral contraceptive agent used.","longName":"ORL_CNPT_AGT_TYP","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C0BAAE-1FC6-7ADE-E053-F662850AE129","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028285","version":"1","preferredName":"Neoplasm Margin Endometrioid Stroma Sarcoma Involvement Status","preferredDefinition":"The response indicating the status of whether the tumor margins are involved with Endometrioid Stroma Sarcoma.","longName":"MRG_EDMTR_SRSRC_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C52DDF-E604-64BC-E053-F662850A39AB","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028286","version":"1","preferredName":"Invasive Endometrioid Stromal Sarcoma Margin Distance Value","preferredDefinition":"The numeric response that indicates the distance from the tumor margin to the Endometrioid Stromal Sarcoma.","longName":"INV_EDMTR_MGR_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C36BCC-6FBA-3F7C-E053-F662850AC79A","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028287","version":"1","preferredName":"Lymph Node Pathologic Assessment Finding Status","preferredDefinition":"The response indicating the status of whether the lymph nodes are involved with endometrial cancer.","longName":"LN_PATH_FIND_ST","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C36BCC-6FE2-3F7C-E053-F662850AC79A","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028288","version":"1","preferredName":"Pelvic Lymph Node Macrometastases Present Count","preferredDefinition":"The numeric response that indicates the number of pelvic lymph nodes that have macrometastases present.","longName":"PLVLN_MACMTS_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-31EA-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028289","version":"1","preferredName":"Pelvic Lymph Node Micrometastases Present Count","preferredDefinition":"The numeric response that indicates the number of pelvic lymph nodes that have micrometastases present.","longName":"PLVLN_MICMTS_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-3212-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028290","version":"1","preferredName":"Pelvic Lymph Node Isolated Tumor Cells Present Count","preferredDefinition":"The numeric response that indicates the number of pelvic lymph nodes that have isolated tumor cells present.","longName":"PLVLN_ISOTUM_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C52DDF-E62C-64BC-E053-F662850A39AB","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028291","version":"1","preferredName":"Para-Aortic Lymph Node Macrometastases Present Count","preferredDefinition":"The numeric response that indicates the number of paraaortic lymph nodes that have macrometastases present.","longName":"PRATC_LN_MACMTS_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C52DDF-E654-64BC-E053-F662850A39AB","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028292","version":"1","preferredName":"Para-Aortic Lymph Node Micrometastases Present Count","preferredDefinition":"The numeric response that indicates the number of paraaortic lymph nodes that have micrometastases present.","longName":"PRATC_LN_MICMTS_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C52DDF-E67C-64BC-E053-F662850A39AB","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028293","version":"1","preferredName":"Para-Aortic Lymph Node Isolated Tumor Cells Present Count","preferredDefinition":"The numeric response that indicates the number of paraaortic lymph nodes that have isolated tumor cells present.","longName":"PRATC_LN_ISOTUM_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4EA3B-A7B9-60D8-E053-F662850AB208","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028294","version":"1","preferredName":"Pelvis Lymph Node Examined Total Count","preferredDefinition":"The numeric response that indicates the total number of pelvic lymph nodes examined.","longName":"PLVLN_EX_TOT_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C2D8FB-4D8F-3F80-E053-F662850ABFC8","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028295","version":"1","preferredName":"Pelvis Sentinel Lymph Node Examined Count","preferredDefinition":"The numeric response that indicates the number of pelvic sentinel lymph nodes examined.","longName":"PLV_SNTLN_EX_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4BC39-323A-5CA8-E053-F662850AD02E","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028296","version":"1","preferredName":"Para-aortic Lymph Node Examined Total Count","preferredDefinition":"The numeric response that indicates the total number of paraaortic lymph nodes examined.","longName":"PRATC_LN_EX_TOT_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C0BAAE-1FEE-7ADE-E053-F662850AE129","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028297","version":"1","preferredName":"Para-aortic Sentinel Lymph Node Examined Count","preferredDefinition":"The numeric response that indicates the number of paraaortic sentinel lymph nodes examined.","longName":"PRATC_SNTLN_EX_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4A281-99B2-6231-E053-F662850AF6C9","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028298","version":"1","preferredName":"Endometrioid Stroma Sarcoma Histologic Grade","preferredDefinition":"The grade representing the extent of endometrioid stroma sarcoma in the body.","longName":"EDMTR_STRSARC_HX_GD","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C4CF3D-A036-63FC-E053-F662850A8EA9","latestVersionIndicator":"Yes","beginDate":"2019-10-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-25","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7029863","version":"1","preferredName":"Endometrial Mixed Cell Adenocarcinoma Histologic Subtype Other Specify","preferredDefinition":"The text response specifying the endometrial mixed cell adenocarcinoma histologic subtypes present.","longName":"ENDMTR_MXCL_SBTP_SPC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FE4E7C-219A-4C90-E053-F662850A96BB","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7029864","version":"1","preferredName":"Endometrial Mixed Cell Adenocarcinoma Histologic Subtype Percentage Value","preferredDefinition":"The text response specifying the percentages present of the endometrial mixed cell adenocarcinoma histologic subtypes.","longName":"ENDMTR_MXCL_PCT_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FFED80-A0A2-0CC2-E053-F662850AFEDF","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7029865","version":"1","preferredName":"Endometrioid Adenocarcinoma Variation Histologic Subtype Other Specify","preferredDefinition":"The text response specifying the endometrioid adenocarcinoma variant histologic subtypes present.","longName":"ENDMTR_SRCM_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FE19C2-79CC-6023-E053-F662850A5DA8","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7029866","version":"1","preferredName":"Endometrioid Adenocarcinoma Other Heterologous Elements Present Histologic Subtype Other Specify","preferredDefinition":"The text response specifying the other heterologous elements present in the endometrioid adenocarcinoma histologic subtype.","longName":"ENDMTR_HTLG_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FF10E5-EF84-408E-E053-F662850A4964","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7029867","version":"1","preferredName":"Other Organ Clinical Involvement Site Other Specify","preferredDefinition":"The text response specifying the other organs/tissues sites that are clinically involved.","longName":"OTH_OGN_INV_OTH_SPEC","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FEE76A-D147-359A-E053-F662850A3EF4","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-07","changeNote":"Curated to support Endometrial content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069579","version":"1","preferredName":"Mitotic Count Assessment Count","preferredDefinition":"Numeric response that indicates the mitoses counted microscopically per high power field.","longName":"MITOTIC_CT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C1FE0C-8127-30B9-E053-F662850AAC42","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069580","version":"1","preferredName":"Mitotic Count Total Area Value","preferredDefinition":"The 2-dimensional surface where mitoses were counted that is enclosed within a boundary measured in mm^2.","longName":"MIT_CT_TOT_AREA_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C196A4-FD34-7FBA-E053-F662850AAFB1","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069581","version":"1","preferredName":"CHGB Gene Expression Immunohistochemistry Staining Method Outcome Value","preferredDefinition":"The numeric response that indicates the quantity of Chromogranin B in ng/ml.","longName":"CHGB_PROT_IHC_OUT_VAL","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C2221F-0526-6947-E053-F662850A38B2","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069582","version":"1","preferredName":"CHGA Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the CHGA mutation was performed.","longName":"CHGA_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C226C8-2C45-7FB4-E053-F662850A253A","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069583","version":"1","preferredName":"CHGA Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the CHGA gene protein expression using immunohistochemistry.","longName":"CHGA_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C2221F-054E-6947-E053-F662850A38B2","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069584","version":"1","preferredName":"SYP Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the SYP mutation was performed.","longName":"SYP_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C1AD86-FFE2-7FBE-E053-F662850AC080","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069585","version":"1","preferredName":"NCAM1 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not immunohistochemical analysis for the NCAM1 mutation was performed.","longName":"NCAM1_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C0E5EC-34D1-7FC4-E053-F662850A326C","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069586","version":"1","preferredName":"NCAM1 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the NCAM1 gene protein expression using immunohistochemistry.","longName":"NCAM1_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C157C5-15CA-7FCA-E053-F662850A41AC","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069587","version":"1","preferredName":"TTF1 Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Text term that represents the status of the TTF1 gene protein expression using immunohistochemistry.","longName":"TTF1_PROT_IHC_OUT","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C19B41-2EB9-1715-E053-F662850A0A72","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7069588","version":"1","preferredName":"TTF1 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Text term that represents the status of the TTF1 gene protein expression using immunohistochemistry.","longName":"TTF1_IHC_PRF_IND","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C24340-2DE6-15A7-E053-F662850AFD66","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeNote":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595944","version":"1","preferredName":"Mesothelioma Margin Involvement Type","preferredDefinition":"Text term representing the involvement by mesothelioma in the margin.","longName":"7592021v1.0:7595743v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD956795-343F-0674-E053-4EBD850ACAFF","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-25","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595945","version":"1","preferredName":"Mesothelioma Margin Involvement Margin Specify","preferredDefinition":"Text field to capture the description of the margin involved by mesothelioma.","longName":"7592021v1.0:7595765v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD95ECD6-79B2-33E9-E053-4EBD850A0AF2","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595947","version":"1","preferredName":"Mesothelioma Treatment Effect Type","preferredDefinition":"Text term representing the kind of treatment effect.","longName":"7592029v1.0:7595743v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD9555A3-8127-3501-E053-4EBD850AAFE7","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-04-14","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc Changes made per HCMI request. 4.14.21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595953","version":"1","preferredName":"Mesothelioma Pathologic Finding Type","preferredDefinition":"Text term representing the additional pathologic findings related to mesothelioma.","longName":"7592031v1.0:7595756v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD984C2B-B0E5-7256-E053-4EBD850A624D","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595957","version":"1","preferredName":"Mesothelioma Pathologic Finding Other Specify","preferredDefinition":"Text field to capture the additional pathologic findings related to mesothelioma which are different than the one previously specified or mentioned.","longName":"7592031v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD9866C5-9390-3002-E053-4EBD850AAAC7","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595961","version":"1","preferredName":"Mesothelioma Inflammation Pathologic Finding Other Specify","preferredDefinition":"Text field to capture the kind of inflammation related to mesothelioma.","longName":"7592034v1.0:2666713v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD986F2E-3CC3-3EA6-E053-4EBD850A8D85","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595962","version":"1","preferredName":"Calretinin Protein Expression Immunohistochemistry Performed Indicator","preferredDefinition":"Indicator of whether or not calretinin protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592038v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD95746D-0982-28C0-E053-4EBD850AB1B0","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595963","version":"1","preferredName":"PDPN Gene Protein Expression D2-40 IHC Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not PDPN protein expression by D2-40 immunohistochemistry (IHC) analysis was performed.","longName":"7595775v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD95746D-09AA-28C0-E053-4EBD850AB1B0","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595964","version":"1","preferredName":"Epithelial Cell Adhesion Molecule Protein Expression BerEp4 IHC Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not epithelial cell adhesion molecule (EPCAM) protein expression by BerEp4 immunohistochemistry (IHC) analysis was performed.","longName":"7595780v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD996934-D4D9-673B-E053-4EBD850ACE20","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595965","version":"1","preferredName":"Ep-CAM Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not EGP-2 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592045v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD996934-D501-673B-E053-4EBD850ACE20","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595966","version":"1","preferredName":"TAG-72 Antigen Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not TAG-72 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592049v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD997527-F170-02B6-E053-4EBD850A0648","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595967","version":"1","preferredName":"Carcinoembryonic Antigen Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not Carcinoembryonic Antigen (CEA) protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592053v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD997527-F198-02B6-E053-4EBD850A0648","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595968","version":"1","preferredName":"Lewis Y Antigen Protein Expression BG8 IHC Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not Lewis Y Antigen protein expression by BG8 immunohistochemistry (IHC) analysis was performed.","longName":"7595784v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A454-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595969","version":"1","preferredName":"Circulating Endothelial Cell Present Examination Indicator","preferredDefinition":"Indicator of whether or not the presence of circulating endothelial cells was examined.","longName":"7595794v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A484-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595970","version":"1","preferredName":"Aquaporin-1 Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not adenovirus encoding human aquaporin-1 protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592093v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A4AC-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595971","version":"1","preferredName":"COX-2 Gene Protein Expression Immunohistochemistry Staining Method Performed Indicator","preferredDefinition":"Indicator of whether or not PTGS2 gene (COX-2) protein expression by immunohistochemistry (IHC) analysis was performed.","longName":"7592096v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A4D7-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595972","version":"1","preferredName":"Thoracic Surgery Talc Pleurodesis Performed Indicator","preferredDefinition":"Indicator of whether or not talc pleurodesis was performed.","longName":"7592105v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A4FF-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7595973","version":"1","preferredName":"Laboratory Procedure Effusion and/or Serum Tumor Marker Test Performed Indicator","preferredDefinition":"Indicator of whether or not other serum and/or effusion marker testing was performed.","longName":"7592114v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD99813E-A527-15F3-E053-4EBD850A3C6C","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601833","version":"1","preferredName":"Calretinin Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the calretinin protein expression using immunohistochemistry.","longName":"7592038v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAA2D49-89C3-225B-E053-4EBD850A1BED","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601834","version":"1","preferredName":"PDPN Gene Protein Expression D2-40 Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the PDPN protein expression using D2-40 immunohistochemistry.","longName":"7595775v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAA2D49-89EB-225B-E053-4EBD850A1BED","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601835","version":"1","preferredName":"Epithelial Cell Adhesion Molecule Protein Expression BerEP4 IHC Staining Method Result","preferredDefinition":"Text term that represents the status of the epithelial cell adhesion Molecule (EPCAM) protein expression using BerEP4 immunohistochemistry.","longName":"7595780v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAA3342-6CBD-1C09-E053-4EBD850A350D","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601836","version":"1","preferredName":"EGP-2 Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the EGP-2 protein expression using immunohistochemistry.","longName":"7592045v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAB19CF-573F-5F92-E053-4EBD850A23C2","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601837","version":"1","preferredName":"TAG-72 Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the tumor-associated oncofetal glycoprotein 72 (TAG-72) protein expression using immunohistochemistry.","longName":"7592049v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAB19CF-5767-5F92-E053-4EBD850A23C2","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601838","version":"1","preferredName":"CEA Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the carcinoembryonic antigen (CEA) protein expression using immunohistochemistry.","longName":"7592053v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAB1CB6-752A-58BD-E053-4EBD850AB4A8","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601839","version":"1","preferredName":"Lewis Y Antigen Protein Expression BG8 Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the Lewis Y antigen protein expression using BG8 immunohistochemistry.","longName":"7595784v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDABA126-6D19-118D-E053-4EBD850AC66D","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601840","version":"1","preferredName":"Aquaporin-1 Protein Expression BG8 IHC Staining Method Result","preferredDefinition":"Text term that represents the status of the adenovirus encoding human aquaporin-1 protein expression using immunohistochemistry.","longName":"7592093v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDABA126-6D4D-118D-E053-4EBD850AC66D","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7601841","version":"1","preferredName":"COX-2 Protein Expression Immunohistochemistry Status Result","preferredDefinition":"Text term that represents the status of the COX-2 (PTGS2 gene) protein expression using immunohistochemistry.","longName":"7592096v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDABBD9C-895E-7C38-E053-4EBD850A07E1","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604207","version":"1","preferredName":"Circulating Endothelial Cell Present Status","preferredDefinition":"Text term representing the status of circulating endothelial cells.","longName":"7595800v1.0:7580731v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAE561F-6ED5-67F2-E053-4EBD850A36EA","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604208","version":"1","preferredName":"Circulating Endothelial Cell Present Number","preferredDefinition":"Numeric representation of the circulating endothelial cells identified.","longName":"7595800v1.0:3297298v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAE561F-6EFD-67F2-E053-4EBD850A36EA","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604209","version":"1","preferredName":"Serum Mesothelin Prior To Treatment Result Value","preferredDefinition":"Numeric representation of the result of serum mesothelin test prior to treatment.","longName":"7592086v1.0:3629928v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAE561F-6F28-67F2-E053-4EBD850A36EA","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604210","version":"1","preferredName":"Programmed Death Ligand 1 Measurement Staining Method Name","preferredDefinition":"The name of the PD-L1 (Programmed Death Ligand 1) stain used for testing.","longName":"7592108v1.0:5406151v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAE561F-6F50-67F2-E053-4EBD850A36EA","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604211","version":"1","preferredName":"Programmed Cell Death Ligand 1 Tumor Cell Positive Finding Percentage Value","preferredDefinition":"Numeric representation of the percent of PD-L1 (Programmed Cell Death Ligand 1) positive cells.","longName":"7592111v1.0:2903088v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAE561F-6F78-67F2-E053-4EBD850A36EA","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604488","version":"1","preferredName":"Laboratory Procedure Effusion and/or Serum Tumor Marker Test Performed Name","preferredDefinition":"The name of the effusion and/or serum tumor marker test performed.","longName":"7592114v1.0:5406151v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBBD988-EFD7-03B1-E053-4EBD850AD87E","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-17","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604489","version":"1","preferredName":"Laboratory Procedure Effusion and/or Serum Tumor Marker Test Performed Value","preferredDefinition":"The numeric result of the effusion and/or serum tumor marker test.","longName":"7592114v1.0:2016796v2.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBBA107-B710-504E-E053-4EBD850AA185","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-17","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604490","version":"1","preferredName":"Laboratory Procedure Effusion and/or Serum Tumor Marker Test Performed Unit of Measure","preferredDefinition":"Text field to capture the unit of measure related to the effusion and/or serum tumor marker test value.","longName":"7592114v1.0:6142349v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBCD0BC-BF38-7D0A-E053-4EBD850A3021","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-17","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7604494","version":"1","preferredName":"Index Date to Effusion and/or Serum Marker Test Day Count","preferredDefinition":"Number of days between the date used for index and the date the effusion and/or serum tumor marker test was performed.","longName":"7604493v1.0:3226255v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDBBA865-B782-524C-E053-4EBD850A9801","latestVersionIndicator":"Yes","beginDate":"2021-03-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-17","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeNote":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7614374","version":"1","preferredName":"Mesothelioma Family History Indicator","preferredDefinition":"Indicator of whether or not there is a family history of mesothelioma.","longName":"7613948v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE4CF0A9-E240-2C32-E053-4EBD850A3021","latestVersionIndicator":"Yes","beginDate":"2021-03-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-24","modifiedBy":"COOPERM","dateModified":"2021-03-25","changeNote":"Created for HCMI: Mesothelioma Curation Request 3/23/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7614375","version":"1","preferredName":"Cytokeratin 5/6 Immunohistochemical Expression Performed Indicator","preferredDefinition":"Indication of whether or not immunohistochemical (IHC) diagnostic test utilizing an antibody to detect both cytokeratin 5 and 6 in tissues was performed.","longName":"7613952v1.0:3506034v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE50051A-3BA2-4A8E-E053-4EBD850A50B3","latestVersionIndicator":"Yes","beginDate":"2021-03-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-24","modifiedBy":"COOPERM","dateModified":"2021-03-25","changeNote":"Created for HCMI: Mesothelioma Curation Request 3/23/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7614376","version":"1","preferredName":"Cytokeratin 5/6 Immunohistochemical Expression Performed Protein Expression IHC Result","preferredDefinition":"Text term representing the result of an immunohistochemical (IHC) diagnostic test utilizing an antibody to detect both cytokeratin 5 and 6 in tissues.","longName":"7613952v1.0:6061805v1.0","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE4DDA2E-7783-408A-E053-4EBD850AC956","latestVersionIndicator":"Yes","beginDate":"2021-03-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-24","modifiedBy":"COOPERM","dateModified":"2021-03-25","changeNote":"Created for HCMI: Mesothelioma Curation Request 3/23/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10216346","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma LymphGen Algorithm Genetic Subtype Category","preferredDefinition":"The response indicating the large B-cell lymphoma genetic subtype identified using the LymphGen algorithm.","longName":"10216310v1.00:10182816v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF253FFF-E4B1-4E37-E053-731AD00A0E79","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-16","modifiedBy":"GDEEN","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10216347","version":"1","preferredName":"Laboratory Procedure Lactate Dehydrogenase Ratio Outcome Value","preferredDefinition":"The numerical response that indicates the amount of lactate dehydrogenase present in a sample expressed as a ratio to the upper limit of normal.","longName":"10216333v1.00:10182815v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF253FFF-E4B3-4E37-E053-731AD00A0E79","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-16","modifiedBy":"GDEEN","dateModified":"2022-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10544802","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Publication Edition Type","preferredDefinition":"The response indicating the edition of the Union for International Cancer Control TNM Classification of Malignant Tumors staging manual.","longName":"10544795v1.00:10544797v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-3DBD-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10672197","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Primary Tumor TNM Finding Category","preferredDefinition":"The response indicating the pathological stage of the primary tumor using the Union for International Cancer Control staging system as a basis for evaluation of the disease.","longName":"10544804v1.00:10544816v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4453E2A-7B77-11C7-E053-731AD00AB62E","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10672198","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Regional Lymph Nodes TNM Finding Category","preferredDefinition":"The response indicating the pathological stage of the regional lymph nodes using the Union for International Cancer Control staging system as a basis for evaluation of the disease.","longName":"10544807v1.00:10544818v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4454A1E-F364-1304-E053-731AD00A0B8F","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10672199","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Pathologic Distant Metastasis TNM Finding Category","preferredDefinition":"The response indicating the pathological stage of the distant metastasis using the Union for International Cancer Control staging system as a basis for evaluation of the disease.","longName":"10544810v1.00:10544820v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4455677-B433-1425-E053-731AD00A2DA4","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10672200","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Clinical Stage","preferredDefinition":"The clinical disease stage of the neoplasm based on the Union for International Cancer Control TNM Staging System.","longName":"10544812v1.00:10672190v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E44589C3-3492-194E-E053-731AD00A2990","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10672201","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Pathologic Stage","preferredDefinition":"The pathological disease stage of the neoplasm based on the Union for International Cancer Control TNM Staging System.","longName":"10544814v1.00:10672193v1.00","contextName":"OCG","contextVersion":"1","dataElementConceptPublicId":"2963683","dataElementConceptVersion":"1","valueDomainPublicId":"2963685","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4459267-A9FF-1A4C-E053-731AD00A31CE","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeNote":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"}]}